ヘルスケアにおける人工知能（AI）市場規模、シェア、動向、2031年までの世界予測

世界のヘルスケアにおける人工知能（AI）市場は、2026年の366億7,000万米ドルから、予測期間中に年平均成長率（CAGR）39.7%で拡大し、2031年には1,947億9,000万米ドルに達するとMarketsandMarketsでは予測しています。病院や医療システムにおいて、臨床業務の効率化、医師のバーンアウト（燃え尽き症候群）の軽減、そして患者の治療成績向上を目指し、AIソリューションの導入が加速していることから、同市場は急速に成長しています。例えば、クリーブランド・クリニックは2025年、80以上の診療科で技術を評価・検証した後、米国内の同院外来ネットワーク全体にAmbience Healthcare社のAIドキュメンテーション・プラットフォームを導入しました。このソリューションは導入後15週間で4,000人以上の臨床医に利用され、100万件を超える患者との診療記録作成を支援しました。さらに2026年1月には、Aultman Health SystemがOracle Cernerとの連携を通じて、数百人の臨床医を対象にNabla社のアンビエントAIソリューションを導入したほか、AtlantiCareはOracle Healthの「Clinical AI Agent」導入後、記録作成にかかる時間を50%削減できたと報告しています。病院、診療所、医療システム全体で実際の導入が進む中、AIは世界中の医療提供の未来を形作る上で、ますます重要な役割を果たすと期待されています。

調査対象範囲

本レポートは、ヘルスケアにおける人工知能（AI）市場を分析し、提供形態、機能、用途、導入モデル、ツール、エンドユーザー、地域といった各セグメントの市場規模および将来の成長性を推定しています。また、市場の成長に影響を与える要因（促進要因、抑制要因、機会、課題など）についても分析を行い、市場関係者にとっての機会と課題を評価しています。さらに、各マイクロマーケット（細分化された市場）の成長動向、見通し、および市場全体への寄与度についても検証しています。主要5地域における各市場セグメントの収益予測に加え、主要企業の競争分析（企業概要、製品ラインナップ、最近の動向、主要な市場戦略など）も提供しています。

本レポートを購入するメリット

本レポートは、既存企業および新規参入企業や中小企業が市場の動向を把握し、市場シェアの拡大につなげる一助となります。本レポートを購入した企業は、以下に挙げる戦略のいずれか、あるいはそれらを組み合わせることで、市場における自社の地位を強化することが可能になります。

本レポートでは、以下の点に関する知見を提供します。

市場の成長要因となる主要な要素の分析：推進要因（医療分野におけるAIの急速な普及と、医療サービス向上へのニーズの高まり）、阻害要因（AI搭載ソリューションを扱う熟練AI専門家の不足、およびAI・ML技術に関する標準化された枠組みの欠如）、機会（医療企業とAI技術プロバイダー間の戦略的提携・協力、人間を理解・配慮するAIシステム開発への注目の高まり）、課題（データプライバシーに関する懸念や相互運用性の欠如）。

• 製品開発・イノベーション：ヘルスケアにおける人工知能（AI）市場の今後のトレンド、研究開発活動、ソフトウェアのリリースに関する詳細な知見。
• 市場展開：有望な新興市場、提供製品・サービス、機能、用途、導入形態、ツール、エンドユーザー、地域に関する包括的な情報。
• 市場の多角化：ヘルスケアにおける人工知能（AI）市場のソフトウェアポートフォリオ、成長地域、最近の動向、投資状況に関する詳細な情報。
• 競争環境の評価：世界のヘルスケアにおける人工知能（AI）市場の主要企業（Koninklijke Philips N.V. [オランダ]、Microsoft Corporation [米国]、Siemens Healthineers AG [ドイツ]、NVIDIA Corporation [米国]、Epic Systems Corporation [米国]など）の市場シェア、成長戦略、製品ラインナップ、企業評価（クアドラント分析）、および能力に関する詳細な評価。

Report Description

The global artificial intelligence (AI) in healthcare market is projected to reach USD 194.79 billion by 2031 from USD 36.67 billion in 2026, at a CAGR of 39.7% during the forecast period. The AI in healthcare market is growing rapidly as hospitals and health systems increasingly deploy AI solutions to improve clinical efficiency, reduce physician burnout, and enhance patient outcomes. For example, in 2025, the Cleveland Clinic rolled out Ambience Healthcare’s AI documentation platform across its US outpatient network after evaluating the technology across more than 80 specialties. The solution was adopted by over 4,000 clinicians within 15 weeks of deployment, enabling documentation for more than one million patient encounters. Additionally, in January 2026, Aultman Health System deployed Nabla’s ambient AI solution across hundreds of clinicians through integration with Oracle Cerner, while AtlantiCare reported a 50% reduction in documentation time after implementing Oracle Health’s Clinical AI Agent. As real-world adoption continues to expand across hospitals, clinics, and health systems, AI is expected to play an increasingly critical role in shaping the future of healthcare delivery worldwide.

By deployment, the cloud-based models segment is expected to register the highest growth during the forecast period.

The AI in healthcare market is categorized into three deployment models: on-premises, cloud-based, and hybrid. The cloud-based models segment holds the largest share due to their scalability, cost-effectiveness, and accessibility. Cloud-based models facilitate real-time data processing and collaboration. They enable seamless integration, secure data storage, and rapid deployment, making them particularly well-suited for healthcare providers and payers. They provide faster, more reliable care while maintaining high-quality standards. Cloud-based AI solutions are becoming increasingly popular due to their cost-effectiveness, scalability, and support for remote access. These solutions enable seamless integration and real-time analytics. The growing adoption of telehealth and advancements in healthcare IT infrastructure further drive the demand for cloud-based models.

By end user, the hospitals & clinics segment dominated the artificial intelligence (AI) in healthcare market for healthcare providers in 2025.

By end user, the artificial intelligence (AI) in healthcare market for healthcare providers is segmented into hospitals & clinics, ambulatory surgical centers, home healthcare agencies & assisted living facilities, diagnostic & imaging centers, pharmacies, and other healthcare providers. The hospitals & clinics segment accounted for the largest share of the artificial intelligence (AI) in healthcare market for healthcare providers. This is attributed to the increasing demand for personalized medicines, precise diagnostics & surgical planning, growth in minimally invasive procedures, and the requirement for interoperability with existing systems. AI-based healthcare solutions enhance diagnostic accuracy, streamline operations, and personalize care in hospitals and clinics. They automate administrative tasks, predict patient outcomes, and enable faster decision-making with real-time data analysis. AI also supports remote monitoring, optimizes resources, and reduces costs by minimizing unnecessary treatments.

The Asia Pacific is expected to register the highest growth during the forecast period.

The artificial intelligence (AI) in healthcare market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is the fastest growing in the AI in healthcare market, driven by rapid healthcare digitalization, increasing investments in artificial intelligence, expanding adoption of electronic health records (EHRs), and strong government support for digital health initiatives. Countries such as China, India, Singapore, Japan, and South Korea are actively integrating AI into diagnostics, medical imaging, clinical decision support, and hospital workflow management. For instance, in February 2026, India launched its Strategy for AI in Healthcare (SAHI), establishing a national framework for the responsible and large-scale adoption of AI across the healthcare ecosystem. Healthcare providers across the region are also expanding AI adoption. In Singapore, the Ministry of Health is scaling generative AI for clinical documentation and AI-powered imaging solutions across the public healthcare system, while hospitals such as Ng Teng Fong General Hospital are using AI-enabled tools to improve patient management and care delivery.

The breakdown of primary participants is as mentioned below:

• By Company Type: Tier 1 (32%), Tier 2 (44%), and Tier 3 (24%)
• By Designation: Directors (30%), Managers (34%), and Others (36%)
• By Region: North America (40%), Europe (28%), Asia Pacific (20%), Latin America (7%), and the Middle East & Africa (5%)

Key Players

The prominent players operating in the artificial intelligence (AI) in healthcare market include Koninklijke Philips N.V. (Netherlands), Microsoft Corporation (US), Siemens Healthineers AG (Germany), NVIDIA Corporation (US), Epic Systems Corporation (US), GE Healthcare (US), Medtronic (US), Oracle (US), Veradigm LLC (US), Merative (IBM) (US), Google (US), Cognizant (US), Johnson & Johnson (US), Amazon Web Services, Inc. (US), SOPHiA GENETICS (US), Riverian Technologies (US), Terarecon (ConcertAI) (US), Solventum Corporation (US), Tempus (US), Viz.ai (US). These companies adopted strategies such as product launches, product updates, expansions, partnerships, collaborations, mergers, and acquisitions to strengthen their market presence in the artificial intelligence (AI) in healthcare market.

Research Coverage

The report analyzes the artificial intelligence (AI) in healthcare market and estimates the market size and future growth potential of various market segments by offering, function, application, deployment model, tool, end user, and region. The report also analyses factors (such as drivers, restrains, opportunities, and challenges) affecting market growth. It evaluates the opportunities and challenges for market stakeholders. The report also examines micromarkets in terms of their growth trends, prospects, and contributions to the total artificial intelligence (AI) in healthcare market. The report forecasts revenue for the market segments across five major regions. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will help established firms, as well as new entrants/smaller firms, gauge the market pulse, which, in turn, will help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the following strategies to strengthen their market positions.

This report provides insights on:

Analysis of key drivers (rapid proliferation of AI in healthcare sector and growing need for improved healthcare services), restraints (shortage of skilled AI professionals handling AI-powered solutions and lack of standardized frameworks for AI and ML technologies), opportunities (strategic partnerships and collaborations among healthcare companies and AI technology providers and increase in focus on developing human-aware AI systems), challenges (concerns regarding data privacy and lack of interoperability) are factors contributing the growth of the artificial intelligence (AI) in healthcare market.

• Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and software launches in the artificial intelligence (AI) in healthcare market.
• Market Development: Comprehensive information on the lucrative emerging markets, offering, function, application, deployment, tool, end user, and region
• Market Diversification: Exhaustive information about software portfolios, growing geographies, recent developments, and investments in the artificial intelligence (AI) in healthcare market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global artificial intelligence (AI) in healthcare market, such as Koninklijke Philips N.V. (Netherlands), Microsoft Corporation (US), Siemens Healthineers AG (Germany), NVIDIA Corporation (US), and Epic Systems Corporation (US).

Table of Contents

1 INTRODUCTION 66
1.1 STUDY OBJECTIVES 66
1.2 MARKET DEFINITION 66
1.3 MARKET SCOPE 67
1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE 67
1.3.2 INCLUSIONS AND EXCLUSIONS 68
1.3.3 YEARS CONSIDERED 71
1.4 CURRENCY CONSIDERED 72
1.5 STAKEHOLDERS 72
2 EXECUTIVE SUMMARY 73
2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS 73
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 75
2.3 DISRUPTIVE TRENDS IN AI IN HEALTHCARE MARKET 76
2.4 HIGH-GROWTH SEGMENTS 77
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 78
3 PREMIUM INSIGHTS 79
3.1 AI IN HEALTHCARE MARKET OVERVIEW 79
3.2 AI IN HEALTHCARE MARKET, BY APPLICATION AND REGION 80
3.3 AI IN HEALTHCARE MARKET: GEOGRAPHIC SNAPSHOT 80
4 MARKET OVERVIEW 81
4.1 INTRODUCTION 81
4.2 MARKET DYNAMICS 81
4.2.1 DRIVERS 82
4.2.1.1 Increasing need for early detection and diagnosis of diseases 82
4.2.1.2 Exponential growth in data volume and complexity due to surging adoption of digital technologies 83
4.2.1.3 Significant cost pressure on healthcare service providers with increasing prevalence of chronic diseases 84
4.2.1.4 Rapid proliferation of AI in healthcare sector 84
4.2.1.5 Growing inclination toward precision medicine and personalized care 85
4.2.2 RESTRAINTS 86
4.2.2.1 Reluctance among medical practitioners to adopt AI-based technologies 86
4.2.2.2 Shortage of skilled AI professionals handling AI-powered solutions 86
4.2.2.3 Lack of standardized frameworks for AI and ML technologies 87
4.2.3 OPPORTUNITIES 87
4.2.3.1 Rising demand for AI-driven clinical decision support systems 87
4.2.3.2 Increasing focus on developing human-aware AI systems 88
4.2.3.3 Strategic partnerships and collaborations among healthcare companies and AI technology providers 89
4.2.3.4 Rising adoption of AI-enabled medical imaging and diagnostics 90
4.2.4 CHALLENGES 91
4.2.4.1 Inaccurate predictions due to scarcity of high-quality healthcare data 91
4.2.4.2 Concerns regarding data privacy 91
4.2.4.3 Lack of interoperability between AI solutions offered by different vendors 92
4.3 UNMET NEEDS AND WHITE SPACES 92
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 93
4.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS 93
5 INDUSTRY TRENDS 94
5.1 PORTER’S FIVE FORCES ANALYSIS 94
5.1.1 THREAT OF NEW ENTRANTS 95
5.1.2 THREAT OF SUBSTITUTES 96
5.1.3 BARGAINING POWER OF SUPPLIERS 96
5.1.4 BARGAINING POWER OF BUYERS 96
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 96
5.2 MACROECONOMIC OUTLOOK 97
5.2.1 INTRODUCTION 97
5.2.2 GDP TRENDS AND FORECAST 97
5.2.3 TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY 97
5.3 VALUE CHAIN ANALYSIS 97
5.4 ECOSYSTEM ANALYSIS 99
5.5 PRICING ANALYSIS 100
5.5.1 INDICATIVE PRICING FOR AI IN HEALTHCARE, BY APPLICATION (2025) 100
5.5.2 INDICATIVE PRICING FOR AI IN HEALTHCARE MARKET, BY REGION (2025) 101
5.6 KEY CONFERENCES AND EVENTS, 2026–2027 102
5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 102
5.8 INVESTMENT AND FUNDING SCENARIO 103
5.9 CASE STUDY ANALYSIS 104
5.9.1 ACCELERATING LUNG CANCER DIAGNOSIS THROUGH AI ACROSS NHS HOSPITALS 104
5.9.2 STRENGTHENING PATIENT TRUST THROUGH DIGITAL PATIENT ENGAGEMENT SOLUTIONS 104
5.9.3 OPTIMIZING PATIENT ENGAGEMENT AND COMMUNICATION WITH TRUBRIDGE PATIENT CONNECT 105
5.10 IMPACT OF US TARIFF – OVERVIEW 105
5.10.1 INTRODUCTION 105
5.10.2 KEY TARIFF RATES 106
5.10.3 PRICE IMPACT ANALYSIS 107
5.10.4 IMPACT ON COUNTRIES/REGIONS 107
5.10.4.1 US 107
5.10.4.2 Europe 108
5.10.4.3 Asia Pacific 109
5.10.5 IMPACT ON END USERS 109
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 111
6.1 KEY EMERGING TECHNOLOGIES 111
6.1.1 MACHINE LEARNING AND DEEP LEARNING 111
6.1.2 NATURAL LANGUAGE PROCESSING 111
6.1.3 COMPUTER VISION 111
6.2 COMPLEMENTARY TECHNOLOGIES 112
6.2.1 CLOUD COMPUTING 112
6.2.2 DIGITAL TWINS 112
6.2.3 ROBOTIC PROCESS AUTOMATION 112
6.3 ADJACENT TECHNOLOGIES 112
6.3.1 BLOCKCHAIN 112
6.3.2 AUGMENTED REALITY AND VIRTUAL REALITY 113
6.3.3 INTERNET OF THINGS 113
6.4 PATENT ANALYSIS 113
6.4.1 PATENT PUBLICATION TRENDS FOR AI IN HEALTHCARE LANDSCAPE 113
6.4.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 114
6.5 FUTURE APPLICATIONS 116
6.5.1 AI-DRIVEN PRECISION MEDICINE 116
6.5.2 REAL-TIME CLINICAL DECISION SUPPORT WITH GENERATIVE AI 117
6.5.3 DISEASE PREDICTION AND EARLY INTERVENTION THROUGH PREDICTIVE ANALYTICS 117
6.5.4 AI-POWERED VIRTUAL HEALTH ASSISTANTS AND DIGITAL CARE NAVIGATION 117
6.5.5 ADVANCING AUTONOMOUS AI AGENTS FOR HEALTHCARE WORKFLOW AUTOMATION 117
7 REGULATORY LANDSCAPE 118
7.1 REGIONAL REGULATIONS AND COMPLIANCE 118
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 118
7.1.2 REGULATORY FRAMEWORK 120
8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR 124
8.1 INTRODUCTION 124
8.2 DECISION-MAKING PROCESS 124
8.3 KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA 124
8.3.1 KEY STAKEHOLDERS IN BUYING PROCESS 125
8.3.2 BUYING CRITERIA 125
8.4 ADOPTION BARRIERS AND INTERNAL CHALLENGES 126
8.5 UNMET NEEDS OF VARIOUS END USERS 127
8.5.1 UNMET NEEDS 127
8.5.2 END-USER EXPECTATIONS 128
8.6 MARKET PROFITABILITY 129
8.7 IMPACT ON COUNTRIES/REGIONS 130
8.7.1 US 130
8.7.2 EUROPE 131
8.7.3 ASIA PACIFIC 131
8.8 IMPACT ON END USERS 132
9 AI IN HEALTHCARE MARKET, BY FUNCTION 133
9.1 INTRODUCTION 134
9.2 DIAGNOSIS & EARLY DETECTION 134
9.2.1 PRE-SCREENING 135
9.2.1.1 Early detection, better outcomes, and cost-effective care associated with pre-screening to boost market 135
9.2.2 IVD 136
9.2.2.1 IVD market, by technology 137
9.2.2.1.1 Immunoassays 137
9.2.2.1.1.1 Potential to enhance biomarker detection and laboratory automation to accelerate demand 137
9.2.2.1.2 Clinical chemistry 138
9.2.2.1.2.1 Ability to improve laboratory efficiency and diagnostic accuracy to spur adoption 138
9.2.2.1.3 Molecular diagnostics 139
9.2.2.1.3.1 Pressing need to identify viral and bacterial pathogens in infectious diseases to facilitate adoption 139
9.2.2.2 IVD market, by application 140
9.2.2.2.1 Image analysis & interpretation 141
9.2.2.2.1.1 Rising focus of pathologists on analyzing tissue samples for detecting abnormalities at faster rate to fuel segmental growth 141
9.2.2.2.2 Biomarker discovery & analysis 142
9.2.2.2.2.1 Elevating adoption of precision medicine to create growth opportunities 142
9.2.2.2.3 Other IVD applications 142
9.2.3 DIAGNOSTIC IMAGING 143
9.2.3.1 Diagnostic imaging market, by application 144
9.2.3.1.1 Disease interpretation & report analysis 144
9.2.3.1.1.1 Proficiency in identifying disease-specific patterns and correlating findings across multiple data sources to fuel adoption 144
9.2.3.1.2 Image captioning & annotation 145
9.2.3.1.2.1 Increasing use of machine learning for automated image captioning to foster market growth 145
9.2.3.1.3 Image reconstruction 146
9.2.3.1.3.1 Greater emphasis of healthcare facilities on optimizing imaging workflows and increasing scanner throughput to augment adoption 146
9.2.3.1.4 Other diagnostic imaging applications 147
9.2.3.2 Diagnostic imaging market, by modality 148
9.2.3.2.1 Magnetic resonance imaging 148
9.2.3.2.1.1 Escalating adoption of AI across MRI workflows to enhance diagnostic confidence and improve scanner utilization to augment market growth 148
9.2.3.2.2 Computed tomography 149
9.2.3.2.2.1 Urgent need for efficient diagnosis to provide the right treatments to drive market 149
9.2.3.2.3 X-ray imaging 150
9.2.3.2.3.1 Development of innovative AI-based X-ray imaging solutions to drive market 150
9.2.3.2.4 Ultrasound 151
9.2.3.2.4.1 Increasing investments in developing AI-assisted ultrasound imaging auto-assessment tools to expedite market growth 151
9.2.3.2.5 Nuclear imaging 152
9.2.3.2.5.1 Integration of AI algorithms for quick detection and monitoring of abnormalities to facilitate market growth 152
9.2.3.2.6 Other diagnostic imaging modalities 153
9.2.4 RISK ASSESSMENT & PATIENT STRATIFICATION 154
9.2.4.1 Critical need to identify high-risk patients and predict their disease progression risks to boost demand 154
9.2.5 DRUG ALLERGY ALERTING 155
9.2.5.1 Significant focus on improving accuracy and speed of identifying allergic reactions to contribute to market growth 155
9.2.6 OTHER DIAGNOSIS & EARLY DETECTION FUNCTIONS 155
9.3 TREATMENT PLANNING & PERSONALIZATION 156
9.3.1 PERSONALIZED TREATMENT PLANNING 157
9.3.1.1 Precision medicine & genomic analysis 158
9.3.1.1.1 Adoption of AI-based software for personalized treatment decisions and improved outcomes to propel market 158
9.3.1.2 Predictive models for treatment response 159
9.3.1.2.1 Ability to personalize therapies, improve outcomes, and minimize adverse effects to fuel growth 159
9.3.1.3 Treatment recommendation systems 160
9.3.1.3.1 Competency in offering personalized, evidence-based treatment options to spike demand 160
9.3.2 PHARMACOLOGICAL THERAPY 161
9.3.2.1 Drug response prediction 162
9.3.2.1.1 Increasing use of AI-powered drug response prediction in oncology and chronic disease management to drive market 162
9.3.2.2 Dosing & administration 163
9.3.2.2.1 Capability of AI-based dosing models to adjust doses in real-time based on individual patient responses to spur demand 163
9.3.2.3 Other pharmacological therapy functions 164
9.3.3 SURGICAL THERAPY 164
9.3.3.1 Preoperative imaging & 3D modeling 165
9.3.3.1.1 Widening use of AI-driven 3D modeling in orthopedic, cardiovascular, neurological surgeries to fuel market growth 165
9.3.3.2 Intraoperative guidance & robotics 166
9.3.3.2.1 Inclination toward minimally invasive surgeries and faster patient recovery to boost implementation 166
9.3.3.3 Postoperative analysis & recovery 167
9.3.3.3.1 Ability to predict recovery patterns, identify risks, and provide personalized rehabilitation plans to boost demand 167
9.3.4 RADIATION THERAPY 168
9.3.4.1 Motion synchronization & auto contouring 169
9.3.4.1.1 Need for precise delivery of radiation and minimum exposure to surrounding healthy tissues to reinforce segmental growth 169
9.3.4.2 Real-time adaptive treatment delivery 170
9.3.4.2.1 Growing focus on consistent treatment accuracy and clinical outcome optimization to strengthen demand 170
9.3.4.3 Response assessment & quality assurance 171
9.3.4.3.1 Ability of AI solutions to analyze medical images, treatment plans, and dosimetric data to accelerate demand 171
9.3.4.4 Other radiation therapy functions 172
9.3.5 BEHAVIORAL THERAPY & PSYCHOTHERAPY 173
9.3.5.1 Virtual counseling & chatbots 174
9.3.5.1.1 Potential to improve patient communication, engagement, and service efficiency to expand implementation 174
9.3.5.2 Progress monitoring & feedback 175
9.3.5.2.1 Increasing use of smart wearables and mobile health apps to drive market 175
9.3.5.3 Follow-up & long-term support 175
9.3.5.3.1 Widespread adoption of telemedicine platforms to drive market expansion 175
9.3.6 IMMUNOTHERAPY 176
9.3.6.1 Real-time patient data monitoring 177
9.3.6.1.1 High demand for proactive healthcare management to foster segmental growth 177
9.3.6.2 Response & side-effect prediction 178
9.3.6.2.1 Need for earlier detection of treatment-related risks across drugs and vaccines to support segmental growth 178
9.3.6.3 Relapse prediction & long-term management 179
9.3.6.3.1 Necessity for continuous patient monitoring and risk stratification to fuel demand 179
9.3.7 OTHER TREATMENT PLANNING & PERSONALIZATION FUNCTIONS 180
9.4 PATIENT ENGAGEMENT & REMOTE MONITORING 181
9.4.1 SYMPTOM MANAGEMENT & VIRTUAL ASSISTANCE 182
9.4.1.1 Constant requirement for symptom management in chronic diseases to accelerate adoption of AI-powered apps 182
9.4.2 TELEHEALTH & REMOTE PATIENT MONITORING 183
9.4.2.1 Increasing adoption of mobile health apps and wearable devices to augment segmental growth 183
9.4.3 HEALTHCARE ASSISTANCE ROBOTS 184
9.4.3.1 Competency in improving quality of care and reducing burden on healthcare workers to promote adoption 184
9.4.4 MEDICATION REMINDERS 185
9.4.4.1 Capability to deliver medication guidance, personalized health coaching, and care coordination to foster demand 185
9.4.5 PATIENT EDUCATION & EMPOWERMENT 186
9.4.5.1 Need to improve treatment adherence and enhance self-management to drive market 186
9.4.6 OTHER PATIENT ENGAGEMENT & REMOTE MONITORING FUNCTIONS 187
9.5 POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE 188
9.5.1 RECURRENCE MONITORING 189
9.5.1.1 Advancing post-treatment care through intelligent recurrence monitoring to support market growth 189
9.5.2 LONG-TERM OUTCOME PREDICTION 189
9.5.2.1 Greater emphasis on predicting disease recurrence and survival chances to improve uptake of AI-powered medical devices 189
9.5.3 MENTAL HEALTH & SUPPORT SYSTEMS 190
9.5.3.1 Rising focus on emotional well-being of patients with critical illness to support segmental growth 190
9.6 PHARMACY MANAGEMENT 191
9.6.1 EPRESCRIBING 192
9.6.1.1 Urgent need to replace paper-based prescription to electronic platform to expedite adoption of ePrescribing solutions 192
9.6.2 MEDICATION MANAGEMENT 193
9.6.2.1 Innovative medication management programs between healthcare professionals and pharmacists to encourage segmental growth 193
9.6.3 PHARMACY AUDIT & ANALYSIS 194
9.6.3.1 Demand for operational excellence and improved patient care outcomes across pharmacies to create growth opportunities 194
9.6.4 OTHER PHARMACY MANAGEMENT FUNCTIONS 195
9.7 DATA MANAGEMENT & ANALYTICS 196
9.7.1 RISING FOCUS OF HEALTHCARE ORGANIZATIONS ON DEVELOPING PERSONALIZED TREATMENT PLANS TO SUPPORT SEGMENTAL GROWTH 196
9.8 AI SCRIBE 196
9.8.1 GROWING NEED TO IMPROVE CLINICIAN PRODUCTIVITY AND REDUCE DOCUMENTATION TIME TO STRENGTHEN AI SCRIBE DEPLOYMENT 196
9.9 CLINICAL DECISION SUPPORT SYSTEMS 197
9.9.1 INCREASING NEED FOR EVIDENCE-BASED CLINICAL DECISION-MAKING TO SPIKE ADOPTION 197
9.10 ADMINISTRATIVE 198
9.10.1 PATIENT REGISTRATION & SCHEDULING 200
9.10.1.1 Rising adoption of self-service patient registration solutions to contribute to segmental growth 200
9.10.2 PATIENT ELIGIBILITY & AUTHORIZATION 201
9.10.2.1 Growing demand for faster prior authorization workflows to facilitate market growth 201
9.10.3 REVENUE CYCLE MANAGEMENT 201
9.10.3.1 Significant need to reduce claim denials and reimbursement delays to reinforce demand 201
9.10.4 WORKFORCE MANAGEMENT 202
9.10.4.1 Growing need to optimize healthcare workforce utilization to create lucrative opportunities 202
9.10.5 SUPPLY CHAIN & INVENTORY MANAGEMENT 203
9.10.5.1 Strong focus on reducing inventory costs and waste to bolster market growth 203
9.10.6 COMPLIANCE & DOCUMENTATION 204
9.10.6.1 Increasing regulatory compliance requirements in healthcare to escalate demand for AI-based compliance & documentation 204
9.10.7 HEALTHCARE WORKFLOW MANAGEMENT 205
9.10.7.1 Surging need for end-to-end workflow automation to foster segmental growth 205
9.10.8 ASSET MANAGEMENT 206
9.10.8.1 Pressing need to improve equipment availability and reduce downtime to heighten demand for AI-based asset management 206
9.10.9 CUSTOMER RELATIONSHIP MANAGEMENT 207
9.10.9.1 Growing focus on personalized patient engagement to boost segmental growth 207
9.10.10 FRAUD DETECTION & RISK MANAGEMENT 208
9.10.10.1 Rising financial losses to drive investment in AI-based proactive risk management solutions 208
9.10.11 CYBERSECURITY 209
9.10.11.1 Critical requirement to protect sensitive patient data to propel demand for AI-powered threat detection solutions 209
9.10.12 OTHER ADMINISTRATIVE FUNCTIONS 210
10 AI IN HEALTHCARE MARKET, BY OFFERING 211
10.1 INTRODUCTION 212
10.2 INTEGRATED SOLUTIONS 212
10.2.1 ESCALATING DEPLOYMENT OF ENTERPRISE-WIDE AI PLATFORMS TO CONTRIBUTE TO SEGMENTAL GROWTH 212
10.3 NICHE/POINT SOLUTIONS 213
10.3.1 GROWING ADOPTION OF SPECIALIZED AI APPLICATIONS FOR TARGETED CLINICAL AND ADMINISTRATIVE TASKS TO DRIVE MARKET 213
10.4 AI TECHNOLOGIES 214
10.4.1 HARNESSING AI FOR IMPROVED PATIENT OUTCOMES AND OPERATIONAL EFFICIENCY TO SUPPORT MARKET GROWTH 214
10.5 SERVICES 215
10.5.1 INCREASING FOCUS ON SEAMLESS AI DEPLOYMENT AND ONGOING SUPPORT TO FACILITATE SEGMENTAL GROWTH 215
11 AI IN HEALTHCARE MARKET, BY APPLICATION 217
11.1 INTRODUCTION 218
11.2 CLINICAL APPLICATIONS 218
11.2.1 NECESSITY TO ENHANCE PATIENT MONITORING AND CLINICAL DECISION-MAKING ABILITY TO SPUR DEMAND 218
11.3 NON-CLINICAL APPLICATIONS 220
11.3.1 REQUIREMENT TO ENHANCE OPERATIONAL EFFICIENCY, REDUCE ADMINISTRATIVE BURDEN, AND ENSURE BETTER RESOURCE ALLOCATION TO FOSTER MARKET GROWTH 220
12 AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL 222
12.1 INTRODUCTION 223
12.2 ON-PREMISES MODEL 223
12.2.1 CRITICALITY OF DATA PRIVACY AND SECURITY TO SUPPORT DEPLOYMENT OF ON-PREMISES HEALTHCARE INFRASTRUCTURE 223
12.3 CLOUD-BASED MODEL 224
12.3.1 RAPID SCALABILITY AND SECURE DATA HANDLING AND INTEGRATION ATTRIBUTES TO ELEVATE DEMAND FOR CLOUD-BASED AI SOLUTIONS IN HEALTHCARE 224
12.4 HYBRID MODEL 225
12.4.1 FOCUS OF HEALTHCARE ORGANIZATIONS ON PROTECTING DATA WITHOUT SACRIFICING SCALABILITY TO DRIVE SEGMENTAL GROWTH 225
13 AI IN HEALTHCARE MARKET, BY TOOL 227
13.1 INTRODUCTION 228
13.2 MACHINE LEARNING 228
13.2.1 DEEP LEARNING 230
13.2.1.1 Convolutional neural networks 231
13.2.1.1.1 Ability to analyze X-rays, CT scans, and MRIs with high precision to elevate adoption 231
13.2.1.2 Recurrent neural networks 232
13.2.1.2.1 Competency in analyzing sequential data to predict disease progression and treatment efficacy to boost deployment 232
13.2.1.3 Generative adversarial networks 233
13.2.1.3.1 Capability to generate synthetic data to train AI models and address data scarcity and privacy issues to propel demand 233
13.2.1.4 Graph neural networks 234
13.2.1.4.1 Ability to recommend personalized treatment to stimulate adoption 234
13.2.1.5 Other deep learning tools 235
13.2.2 SUPERVISED LEARNING 236
13.2.2.1 Growing importance of evidence-based decision-making in predictive and diagnostic tasks to spur demand 236
13.2.3 REINFORCEMENT LEARNING 237
13.2.3.1 Significance of precision medicine, value-based care, and intelligent clinical decision support to accelerate demand 237
13.2.4 UNSUPERVISED LEARNING 238
13.2.4.1 Increasing need to uncover hidden insights from unstructured healthcare data to boost adoption 238
13.2.5 OTHER MACHINE LEARNING TOOLS 238
13.3 NATURAL LANGUAGE PROCESSING 239
13.3.1 SENTIMENT ANALYSIS 241
13.3.1.1 Increasing adoption of AI for patient feedback analysis to contribute to market growth 241
13.3.2 PATTERN & IMAGE RECOGNITION 241
13.3.2.1 Growing utilization of AI for early disease detection and personalized treatment planning to facilitate market expansion 241
13.3.3 AUTO CODING 242
13.3.3.1 Elevating use of AI tools to improve claim reimbursement process to fuel market growth 242
13.3.4 CLASSIFICATION & CATEGORIZATION 243
13.3.4.1 Business need to organize and classify healthcare data efficiently to expand AI implementation 243
13.3.5 TEXT ANALYTICS 244
13.3.5.1 Necessity to derive insights from unstructured clinical text to enhance use of text analytics 244
13.3.6 SPEECH RECOGNITION 244
13.3.6.1 Rising focus on reducing physician administrative burden to accelerate demand 244
13.4 CONTEXT-AWARE COMPUTING 245
13.4.1 DEVICE CONTEXT 246
13.4.1.1 Integration of connected medical devices to boost demand for intelligent device-aware healthcare applications 246
13.4.2 USER CONTEXT 247
13.4.2.1 Rising focus on individualized clinical decision support to spike demand 247
13.4.3 PHYSICAL CONTEXT 248
13.4.3.1 Increasing adoption of AI for real-time environmental and patient context monitoring to generate demand 248
13.5 GENERATIVE AI 249
13.5.1 INCREASING USE OF GENERATIVE MODELS TO OFFER TAILORED INTERVENTIONS TO DRIVE MARKET 249
13.6 COMPUTER VISION 249
13.6.1 ABILITY TO DETECT ABNORMALITIES SUCH AS TUMORS AND FRACTURES TO FUEL ADOPTION 249
13.7 IMAGE ANALYSIS 251
13.7.1 GROWING ADOPTION OF AI FOR EARLY DISEASE DETECTION AND DIAGNOSIS TO CONTRIBUTE TO MARKT GROWTH 251
14 AI IN HEALTHCARE MARKET, BY END USER 252
14.1 INTRODUCTION 253
14.2 HEALTHCARE PROVIDERS 253
14.2.1 HOSPITALS & CLINICS 255
14.2.1.1 Increasing focus on enhancing patient outcomes through AI to expedite market expansion 255
14.2.2 AMBULATORY CARE CENTERS 256
14.2.2.1 Rising adoption of AI to reduce care delivery costs to reinforce market growth 256
14.2.3 HOME HEALTHCARE AGENCIES & ASSISTED-LIVING FACILITIES 257
14.2.3.1 Escalating demand for personalized and continuous patient care to accelerate market growth 257
14.2.4 DIAGNOSTIC & IMAGING CENTERS 258
14.2.4.1 Increasing partnerships between hospitals and imaging centers to develop regulatory-cleared AI tools to support market growth 258
14.2.5 PHARMACIES 259
14.2.5.1 Heightened need for AI-driven inventory optimization to unlock opportunities 259
14.2.6 OTHER HEALTHCARE PROVIDERS 260
14.3 HEALTHCARE PAYERS 260
14.3.1 PUBLIC PAYERS 262
14.3.1.1 Increasing focus on cost optimization and fraud prevention to promote adoption of AI by public payers 262
14.3.2 PRIVATE PAYERS 263
14.3.2.1 Leveraging AI to optimize claims management, member engagement, and value-based care programs to drive market 263
14.4 PATIENTS 264
14.4.1 INCREASING ADOPTION OF AI FOR PATIENT ENGAGEMENT AND SELF-CARE TO FACILITATE MARKET GROWTH 264
14.5 OTHER END USERS 265
15 AI IN HEALTHCARE MARKET, BY REGION 266
15.1 INTRODUCTION 267
15.2 NORTH AMERICA 267
15.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 269
15.2.2 US 284
15.2.2.1 Increasing focus on personalized medicine and precision healthcare to drive market 284
15.2.3 CANADA 298
15.2.3.1 Rising use of AI to improve disease care and patient survival and clinical workflows to drive market 298
15.3 EUROPE 312
15.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 312
15.3.2 GERMANY 327
15.3.2.1 Collaborative health-related research and innovation programs and initiatives to contribute to market growth 327
15.3.3 UK 340
15.3.3.1 Significant focus of government on early diagnosis, personalized treatments, and rapid drug development to boost AI demand 340
15.3.4 FRANCE 354
15.3.4.1 Expanding AI-enabled digital healthcare and patient services to foster market growth 354
15.3.5 ITALY 368
15.3.5.1 Growing deployment of AI infrastructure to ensure transparency, data protection, and patient safety to facilitate market growth 368
15.3.6 SPAIN 382
15.3.6.1 Partnerships between scientists, medical professionals, and AI experts to develop innovative diagnostic tools to drive market 382
15.3.7 REST OF EUROPE 395
15.4 ASIA PACIFIC 410
15.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 411
15.4.2 CHINA 424
15.4.2.1 Growing focus on healthcare innovation through national AI initiatives to accelerate market growth 424
15.4.3 JAPAN 438
15.4.3.1 Strong healthcare infrastructure to drive adoption of advanced AI 438
15.4.4 INDIA 450
15.4.4.1 Strong government support for digital health initiatives to create lucrative opportunities 450
15.4.5 AUSTRALIA 464
15.4.5.1 Strong research ecosystem and national digital health initiatives to drive market 464
15.4.6 SOUTH KOREA 477
15.4.6.1 National Strategy for Artificial Intelligence and Digital Healthcare Innovation Plan initiatives to support market growth 477
15.4.7 REST OF ASIA PACIFIC 490
15.5 LATIN AMERICA 504
15.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 504
15.5.2 BRAZIL 517
15.5.2.1 Expanding digital health infrastructure and growing adoption of AI-enabled healthcare technologies to foster market growth 517
15.5.3 MEXICO 530
15.5.3.1 Growing adoption of AI-driven chronic disease management platforms to stimulate market growth 530
15.5.4 REST OF LATIN AMERICA 543
15.6 MIDDLE EAST & AFRICA 556
15.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 557
15.6.2 GCC 570
15.6.2.1 Saudi Arabia 583
15.6.2.1.1 Accelerating AI-driven healthcare transformation under Saudi Vision 2030 to contribute to market growth 583
15.6.2.2 UAE 596
15.6.2.2.1 Rising focus on improving healthcare quality and delivering personalized patient care to reinforce market growth 596
15.6.2.3 Rest of GCC 609
15.6.3 SOUTH AFRICA 622
15.6.3.1 Expanding use of AI to enhance medical imaging, clinical decision support, and disease surveillance to drive market 622
15.6.4 REST OF MIDDLE EAST & AFRICA 635
16 COMPETITIVE LANDSCAPE 649
16.1 INTRODUCTION 649
16.2 KEY PLAYER COMPETITIVE STRATEGY/RIGHT TO WIN, JANUARY 2023 TO JUNE 2026 649
16.3 REVENUE ANALYSIS, 2021–2025 652
16.4 MARKET SHARE ANALYSIS, 2025 653
16.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 655
16.5.1 STARS 655
16.5.2 EMERGING LEADERS 655
16.5.3 PERVASIVE PLAYERS 655
16.5.4 PARTICIPANTS 655
16.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 657
16.5.5.1 Company footprint 657
16.5.5.2 Region footprint 658
16.5.5.3 Application footprint 659
16.5.5.4 Tool footprint 660
16.5.5.5 Function footprint 661
16.5.5.6 Offering footprint 662
16.5.5.7 Deployment footprint 663
16.5.5.8 End user footprint 664
16.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 665
16.6.1 PROGRESSIVE COMPANIES 665
16.6.2 RESPONSIVE COMPANIES 665
16.6.3 DYNAMIC COMPANIES 665
16.6.4 STARTING BLOCKS 665
16.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 667
16.6.5.1 Detailed list of key startups/SMEs 667
16.6.5.2 Company footprint (startups/SMEs) 667
16.7 COMPANY VALUATION AND FINANCIAL METRICS 668
16.7.1 FINANCIAL METRICS 668
16.7.2 COMPANY VALUATION 668
16.8 BRAND/PRODUCT COMPARISON 669
16.9 COMPETITIVE SCENARIO 669
16.9.1 PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 669
16.9.2 DEALS 671
16.9.3 OTHER DEVELOPMENTS 672
17 COMPANY PROFILES 673
17.1 KEY PLAYERS 673
17.1.1 KONINKLIJKE PHILIPS N.V. 673
17.1.1.1 Business overview 673
17.1.1.2 Products & services offered 674
17.1.1.3 Recent developments 676
17.1.1.3.1 Product launches/enhancements/approvals 676
17.1.1.3.2 Deals 678
17.1.1.3.3 Expansions 680
17.1.1.3.4 Other developments 681
17.1.1.4 MnM view 681
17.1.1.4.1 Right to win 681
17.1.1.4.2 Strategic choices 681
17.1.1.4.3 Weaknesses & competitive threats 681
17.1.2 MICROSOFT CORPORATION 682
17.1.2.1 Business overview 682
17.1.2.2 Products & services offered 683
17.1.2.3 Recent developments 685
17.1.2.3.1 Product launches/enhancements/approvals 685
17.1.2.3.2 Deals 686
17.1.2.4 MnM view 688
17.1.2.4.1 Right to win 688
17.1.2.4.2 Strategic choices 688
17.1.2.4.3 Weaknesses & competitive threats 688
17.1.3 NVIDIA CORPORATION 689
17.1.3.1 Business overview 689
17.1.3.2 Products & services offered 690
17.1.3.3 Recent developments 691
17.1.3.3.1 Product launches/enhancements/approvals 691
17.1.3.3.2 Deals 692
17.1.3.4 MnM view 694
17.1.3.4.1 Right to win 694
17.1.3.4.2 Strategic choices 694
17.1.3.4.3 Weaknesses & competitive threats 694
17.1.4 SIEMENS HEALTHINEERS AG 695
17.1.4.1 Business overview 695
17.1.4.2 Products & services offered 696
17.1.4.3 Recent developments 698
17.1.4.3.1 Product launches/enhancements/approvals 698
17.1.4.3.2 Deals 699
17.1.4.4 MnM view 700
17.1.4.4.1 Right to win 700
17.1.4.4.2 Strategic choices 701
17.1.4.4.3 Weaknesses & competitive threats 701
17.1.5 GE HEALTHCARE 702
17.1.5.1 Business overview 702
17.1.5.2 Products & services offered 703
17.1.5.3 Recent developments 705
17.1.5.3.1 Product launches/enhancements/approvals 705
17.1.5.3.2 Deals 705
17.1.5.3.3 Other developments 707
17.1.5.4 MnM view 707
17.1.5.4.1 Right to win 707
17.1.5.4.2 Strategic choices 707
17.1.5.4.3 Weaknesses & competitive threats 707
17.1.6 EPIC SYSTEMS CORPORATION 708
17.1.6.1 Business overview 708
17.1.6.2 Products & services offered 708
17.1.6.3 Recent developments 709
17.1.6.3.1 Product launches/enhancements/approvals 709
17.1.6.3.2 Deals 709
17.1.7 ORACLE 710
17.1.7.1 Business overview 710
17.1.7.2 Products & services offered 711
17.1.7.3 Recent developments 712
17.1.7.3.1 Product launches/enhancements/approvals 712
17.1.7.3.2 Deals 713
17.1.7.3.3 Expansions 714
17.1.8 VERADIGM INC. 715
17.1.8.1 Business overview 715
17.1.8.2 Products & services offered 715
17.1.8.3 Recent developments 716
17.1.8.3.1 Product launches/enhancements/approvals 716
17.1.8.3.2 Deals 717
17.1.9 AMAZON WEB SERVICES, INC. 718
17.1.9.1 Business overview 718
17.1.9.2 Products & services offered 719
17.1.9.3 Recent developments 720
17.1.9.3.1 Product launches/enhancements/approvals 720
17.1.9.3.2 Deals 721
17.1.9.3.3 Expansions 722
17.1.10 MERATIVE 723
17.1.10.1 Business overview 723
17.1.10.2 Products & services offered 723
17.1.10.3 Recent developments 724
17.1.10.3.1 Product launches/enhancements/approvals 724
17.1.10.3.2 Deals 724
17.1.11 IBM 725
17.1.11.1 Business overview 725
17.1.11.2 Products & services offered 726
17.1.11.3 Recent developments 727
17.1.11.3.1 Deals 727
17.1.12 MEDTRONIC 728
17.1.12.1 Business overview 728
17.1.12.2 Products & services offered 729
17.1.12.3 Recent developments 730
17.1.12.3.1 Product launches/enhancements/approvals 730
17.1.12.3.2 Deals 731
17.1.13 GOOGLE 732
17.1.13.1 Business overview 732
17.1.13.2 Products & services offered 733
17.1.13.3 Recent developments 735
17.1.13.3.1 Product launches/enhancements/approvals 735
17.1.13.3.2 Deals 736
17.1.13.3.3 Other developments 738
17.1.14 SOPHIA GENETICS 739
17.1.14.1 Business overview 739
17.1.14.2 Products & services offered 740
17.1.14.3 Recent developments 740
17.1.14.3.1 Product launches/enhancements/approvals 740
17.1.14.3.2 Deals 741
17.1.14.3.3 Other developments 742
17.1.15 JOHNSON & JOHNSON SERVICES, INC. 743
17.1.15.1 Business overview 743
17.1.15.2 Products & services offered 744
17.1.15.3 Recent developments 745
17.1.15.3.1 Product launches/enhancements/approvals 745
17.1.15.3.2 Deals 745
17.1.16 TEMPUS AI, INC. 746
17.1.16.1 Business overview 746
17.1.16.2 Products & services offered 747
17.1.16.3 Recent developments 748
17.1.16.3.1 Product launches/enhancements/approvals 748
17.1.16.3.2 Deals 749
17.1.17 CONCERTAI 751
17.1.17.1 Business overview 751
17.1.17.2 Products & services offered 751
17.1.17.3 Recent developments 752
17.1.17.3.1 Product launches/enhancements/approvals 752
17.1.17.3.2 Deals 753
17.1.18 SOLVENTUM CORPORATION 755
17.1.18.1 Business overview 755
17.1.18.2 Products & services offered 756
17.1.18.3 Recent developments 757
17.1.18.3.1 Deals 757
17.1.18.3.2 Other developments 758
17.1.19 COGNIZANT 759
17.1.19.1 Business overview 759
17.1.19.2 Products & services offered 760
17.1.19.3 Recent developments 761
17.1.19.3.1 Product launches/enhancements/approvals 761
17.1.19.3.2 Deals 762
17.1.20 VIZ.AI, INC. 763
17.1.20.1 Business overview 763
17.1.20.2 Products & services offered 763
17.1.20.3 Recent developments 764
17.1.20.3.1 Product launches/enhancements/approvals 764
17.1.20.3.2 Deals 764
17.1.20.3.3 Other developments 766
17.1.21 RIVERAIN TECHNOLOGIES 767
17.1.21.1 Business overview 767
17.1.21.2 Products & services offered 767
17.1.21.3 Recent developments 768
17.1.21.3.1 Product launches/enhancements/approvals 768
17.1.21.3.2 Deals 768
17.2 OTHER PLAYERS 770
17.2.1 QVENTUS 770
17.2.2 QURE.AI 771
17.2.3 SUKI AI, INC. 772
17.2.4 ENLITIC 773
17.2.5 SEGMED 773
18 RESEARCH METHODOLOGY 774
18.1 RESEARCH DATA 774
18.1.1 SECONDARY DATA 775
18.1.1.1 Key data from secondary sources 776
18.1.2 PRIMARY DATA 776
18.1.2.1 Key data from primary sources 778
18.1.2.2 Key industry insights 778
18.2 MARKET SIZE ESTIMATION 779
18.3 DATA TRIANGULATION 784
18.4 MARKET SHARE ESTIMATION 785
18.5 RESEARCH ASSUMPTIONS 785
18.6 RESEARCH LIMITATIONS 785
18.6.1 METHODOLOGY-RELATED LIMITATIONS 785
18.6.2 SCOPE-RELATED LIMITATIONS 785
18.7 RISK ASSESSMENT 786
19 APPENDIX 787
19.1 DISCUSSION GUIDE 787
19.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 794
19.3 CUSTOMIZATION OPTIONS 796
19.4 RELATED REPORTS 796
19.5 AUTHOR DETAILS 797

LIST OF TABLES

TABLE 1 INCLUSIONS AND EXCLUSIONS 68
TABLE 2 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 72
TABLE 3 AI IN HEALTHCARE MARKET: IMPACT ANALYSIS 82
TABLE 4 ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET: PORTER’S FIVE FORCES ANALYSIS 94
TABLE 5 AI IN HEALTHCARE MARKET: ROLE IN ECOSYSTEM 100
TABLE 6 INDICATIVE PRICING FOR AI IN HEALTHCARE, BY NON-CLINICAL APPLICATION (2025) 101
TABLE 7 INDICATIVE PRICING FOR AI IN HEALTHCARE, BY CLINICAL APPLICATION (2025) 101
TABLE 8 CASE 1: AI-ENABLED LUNG CANCER DIAGNOSIS IN NHS HOSPITALS 104
TABLE 9 CASE 2: AI-DRIVEN PATIENT ENGAGEMENT IN CHILDREN’S HEALTHCARE 104
TABLE 10 CASE 3: DIGITAL PATIENT ENGAGEMENT AT SPARTA COMMUNITY HOSPITAL 105
TABLE 11 US-ADJUSTED RECIPROCAL TARIFF RATES 106
TABLE 12 EXPECTED CHANGE IN PRICES AND LIKELY IMPACT ON END-USE MARKET DUE TO TARIFF IMPACT 107
TABLE 13 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR AI IN HEALTHCARE SECTOR 114
TABLE 14 AI IN HEALTHCARE MARKET: LIST OF PATENTS/PATENT APPLICATIONS,
2022–2024 115
TABLE 15 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 118
TABLE 16 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 119
TABLE 17 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 119
TABLE 18 NORTH AMERICA 120
TABLE 19 EUROPE 121
TABLE 20 ASIA PACIFIC 121
TABLE 21 MIDDLE EAST & AFRICA 122
TABLE 22 LATIN AMERICA 123
TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP 3 END USERS (%) 125
TABLE 24 KEY BUYING CRITERIA FOR TOP 3 END USERS 126
TABLE 25 UNMET NEEDS IN AI IN HEALTHCARE MARKET 127
TABLE 26 END-USER EXPECTATIONS IN AI IN HEALTHCARE MARKET 128
TABLE 27 EXPECTED CHANGE IN PRICES AND ANTICIPATED IMPACT ON END USERS DUE TO TARIFF IMPACT 129
TABLE 28 AI IN HEALTHCARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 134
TABLE 29 AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024–2031 (USD MILLION) 135
TABLE 30 AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY REGION, 2024–2031 (USD MILLION) 135
TABLE 31 AI IN HEALTHCARE MARKET FOR PRE-SCREENING, BY REGION,
2024–2031 (USD MILLION) 136
TABLE 32 AI IN HEALTHCARE MARKET FOR IVD, BY REGION, 2024–2031 (USD MILLION) 137
TABLE 33 AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,
2024–2031 (USD MILLION) 137
TABLE 34 AI IN HEALTHCARE MARKET FOR IMMUNOASSAYS, BY REGION,
2024–2031 (USD MILLION) 138
TABLE 35 AI IN HEALTHCARE MARKET FOR CLINICAL CHEMISTRY, BY REGION,
2024–2031 (USD MILLION) 139
TABLE 36 AI IN HEALTHCARE MARKET FOR MOLECULAR DIAGNOSTICS, BY REGION,
2024–2031 (USD MILLION) 140
TABLE 37 AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024–2031 (USD MILLION) 140
TABLE 38 AI IN HEALTHCARE MARKET FOR IMAGE ANALYSIS & INTERPRETATION, BY REGION, 2024–2031 (USD MILLION) 141
TABLE 39 AI IN HEALTHCARE MARKET FOR BIOMARKER DISCOVERY & ANALYSIS, BY REGION, 2024–2031 (USD MILLION) 142
TABLE 40 AI IN HEALTHCARE MARKET FOR OTHER IVD APPLICATIONS, BY REGION,
2024–2031 (USD MILLION) 143
TABLE 41 AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY REGION,
2024–2031 (USD MILLION) 143
TABLE 42 AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION,
2024–2031 (USD MILLION) 144
TABLE 43 AI IN HEALTHCARE MARKET FOR DISEASE INTERPRETATION & REPORT ANALYSIS, BY REGION, 2024–2031 (USD MILLION) 145
TABLE 44 AI IN HEALTHCARE MARKET FOR IMAGE CAPTIONING & ANNOTATION, BY REGION, 2024–2031 (USD MILLION) 146
TABLE 45 AI IN HEALTHCARE MARKET FOR IMAGE RECONSTRUCTION, BY REGION,
2024–2031 (USD MILLION) 147
TABLE 46 AI IN HEALTHCARE MARKET FOR OTHER DIAGNOSTIC IMAGING, BY REGION, 2024–2031 (USD MILLION) 147
TABLE 47 AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY,
2024–2031 (USD MILLION) 148
TABLE 48 AI IN HEALTHCARE MARKET FOR MAGNETIC RESONANCE IMAGING, BY REGION, 2024–2031 (USD MILLION) 149
TABLE 49 AI IN HEALTHCARE MARKET FOR COMPUTED TOMOGRAPHY, BY REGION,
2024–2031 (USD MILLION) 150
TABLE 50 AI IN HEALTHCARE MARKET FOR X-RAY IMAGING, BY REGION,
2024–2031 (USD MILLION) 151
TABLE 51 AI IN HEALTHCARE MARKET FOR ULTRASOUND, BY REGION,
2024–2031 (USD MILLION) 152
TABLE 52 AI IN HEALTHCARE MARKET FOR NUCLEAR IMAGING, BY REGION,
2024–2031 (USD MILLION) 153
TABLE 53 AI IN HEALTHCARE MARKET FOR OTHER DIAGNOSTIC IMAGING MODALITIES,
BY REGION, 2024–2031 (USD MILLION) 153
TABLE 54 AI IN HEALTHCARE MARKET FOR RISK ASSESSMENT & PATIENT STRATIFICATION, BY REGION, 2024–2031 (USD MILLION) 154
TABLE 55 AI IN HEALTHCARE MARKET FOR DRUG ALLERGY ALERTING, BY REGION,
2024–2031 (USD MILLION) 155
TABLE 56 AI IN HEALTHCARE MARKET FOR OTHER DIAGNOSIS & EARLY DETECTION FUNCTIONS, BY REGION, 2024–2031 (USD MILLION) 156
TABLE 57 AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION,
BY TYPE, 2024–2031 (USD MILLION) 156
TABLE 58 AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION,
BY REGION, 2024–2031 (USD MILLION) 157
TABLE 59 AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 158
TABLE 60 AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING,
BY REGION, 2024–2031 (USD MILLION) 158
TABLE 61 AI IN HEALTHCARE MARKET FOR PRECISION MEDICINE & GENOMIC ANALYSIS,
BY REGION, 2024–2031 (USD MILLION) 159
TABLE 62 AI IN HEALTHCARE MARKET FOR PREDICTIVE MODELS FOR TREATMENT RESPONSE, BY REGION, 2024–2031 (USD MILLION) 160
TABLE 63 AI IN HEALTHCARE MARKET FOR TREATMENT RECOMMENDATION SYSTEMS,
BY REGION, 2024–2031 (USD MILLION) 161
TABLE 64 AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE,
2024–2031 (USD MILLION) 161
TABLE 65 AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY REGION, 2024–2031 (USD MILLION) 162
TABLE 66 AI IN HEALTHCARE MARKET FOR DRUG RESPONSE PREDICTION, BY REGION, 2024–2031 (USD MILLION) 163
TABLE 67 AI IN HEALTHCARE MARKET FOR DOSING & ADMINISTRATION, BY REGION,
2024–2031 (USD MILLION) 164
TABLE 68 AI IN HEALTHCARE MARKET FOR OTHER PHARMACOLOGICAL THERAPY FUNCTIONS, BY REGION, 2024–2031 (USD MILLION) 164
TABLE 69 AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE,
2024–2031 (USD MILLION) 165
TABLE 70 AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY REGION,
2024–2031 (USD MILLION) 165
TABLE 71 AI IN HEALTHCARE MARKET FOR PREOPERATIVE IMAGING & 3D MODELING,
BY REGION, 2024–2031 (USD MILLION) 166
TABLE 72 AI IN HEALTHCARE MARKET FOR INTRAOPERATIVE GUIDANCE & ROBOTICS,
BY REGION, 2024–2031 (USD MILLION) 167
TABLE 73 AI IN HEALTHCARE MARKET FOR POSTOPERATIVE ANALYSIS & RECOVERY,
BY REGION, 2024–2031 (USD MILLION) 168
TABLE 74 AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE,
2024–2031 (USD MILLION) 169
TABLE 75 AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY REGION,
2024–2031 (USD MILLION) 169
TABLE 76 AI IN HEALTHCARE MARKET FOR MOTION SYNCHRONIZATION & AUTO CONTOURING, BY REGION, 2024–2031 (USD MILLION) 170
TABLE 77 AI IN HEALTHCARE MARKET FOR REAL-TIME ADAPTIVE TREATMENT DELIVERY,
BY REGION, 2024–2031 (USD MILLION) 171
TABLE 78 AI IN HEALTHCARE MARKET FOR RESPONSE ASSESSMENT & QUALITY ASSURANCE, BY REGION, 2024–2031 (USD MILLION) 172
TABLE 79 AI IN HEALTHCARE MARKET FOR OTHER RADIATION THERAPY FUNCTIONS,
BY REGION, 2024–2031 (USD MILLION) 172
TABLE 80 AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY,
BY TYPE, 2024–2031 (USD MILLION) 173
TABLE 81 AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY,
BY REGION, 2024–2031 (USD MILLION) 173
TABLE 82 AI IN HEALTHCARE MARKET FOR VIRTUAL COUNSELING & CHATBOTS, BY REGION, 2024–2031 (USD MILLION) 174
TABLE 83 AI IN HEALTHCARE MARKET FOR PROGRESS MONITORING & FEEDBACK,
BY REGION, 2024–2031 (USD MILLION) 175
TABLE 84 AI IN HEALTHCARE MARKET FOR FOLLOW-UP & LONG-TERM SUPPORT, BY REGION, 2024–2031 (USD MILLION) 176
TABLE 85 AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE,
2024–2031 (USD MILLION) 177
TABLE 86 AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY REGION,
2024–2031 (USD MILLION) 177
TABLE 87 AI IN HEALTHCARE MARKET FOR REAL-TIME PATIENT DATA MONITORING,
BY REGION, 2024–2031 (USD MILLION) 178
TABLE 88 AI IN HEALTHCARE MARKET FOR RESPONSE & SIDE-EFFECT PREDICTION,
BY REGION, 2024–2031 (USD MILLION) 179
TABLE 89 AI IN HEALTHCARE MARKET FOR RELAPSE PREDICTION & LONG-TERM MANAGEMENT, BY REGION, 2024–2031 (USD MILLION) 180
TABLE 90 AI IN HEALTHCARE MARKET FOR OTHER TREATMENT PLANNING & PERSONALIZATION FUNCTIONS, BY REGION, 2024–2031 (USD MILLION) 180
TABLE 91 AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 181
TABLE 92 AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY REGION, 2024–2031 (USD MILLION) 182
TABLE 93 AI IN HEALTHCARE MARKET FOR SYMPTOM MANAGEMENT & VIRTUAL ASSISTANCE, BY REGION, 2024–2031 (USD MILLION) 183
TABLE 94 AI IN HEALTHCARE MARKET FOR TELEHEALTH & REMOTE PATIENT MONITORING, BY REGION, 2024–2031 (USD MILLION) 184
TABLE 95 AI IN HEALTHCARE MARKET FOR HEALTHCARE ASSISTANCE ROBOTS, BY REGION, 2024–2031 (USD MILLION) 185
TABLE 96 AI IN HEALTHCARE MARKET FOR MEDICATION REMINDERS, BY REGION,
2024–2031 (USD MILLION) 186
TABLE 97 AI IN HEALTHCARE MARKET FOR PATIENT EDUCATION & EMPOWERMENT,
BY REGION, 2024–2031 (USD MILLION) 187
TABLE 98 AI IN HEALTHCARE MARKET FOR OTHER PATIENT ENGAGEMENT & REMOTE MONITORING FUNCTIONS, BY REGION, 2024–2031 (USD MILLION) 187
TABLE 99 AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 188
TABLE 100 AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY REGION, 2024–2031 (USD MILLION) 188
TABLE 101 AI IN HEALTHCARE MARKET FOR RECURRENCE MONITORING, BY REGION,
2024–2031 (USD MILLION) 189
TABLE 102 AI IN HEALTHCARE MARKET FOR LONG-TERM OUTCOME PREDICTION, BY REGION, 2024–2031 (USD MILLION) 190
TABLE 103 AI IN HEALTHCARE MARKET FOR MENTAL HEALTH & SUPPORT SYSTEMS,
BY REGION, 2024–2031 (USD MILLION) 191
TABLE 104 AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE,
2024–2031 (USD MILLION) 191
TABLE 105 AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY REGION, 2
024–2031 (USD MILLION) 192
TABLE 106 AI IN HEALTHCARE MARKET FOR EPRESCRIBING, BY REGION,
2024–2031 (USD MILLION) 193
TABLE 107 AI IN HEALTHCARE MARKET FOR MEDICATION MANAGEMENT, BY REGION,
2024–2031 (USD MILLION) 194
TABLE 108 AI IN HEALTHCARE MARKET FOR PHARMACY AUDIT & ANALYSIS, BY REGION, 2024–2031 (USD MILLION) 195
TABLE 109 AI IN HEALTHCARE MARKET FOR OTHER PHARMACY MANAGEMENT FUNCTIONS, BY REGION, 2024–2031 (USD MILLION) 195
TABLE 110 AI IN HEALTHCARE MARKET FOR DATA MANAGEMENT & ANALYTICS FUNCTIONS, BY REGION, 2024–2031 (USD MILLION) 196
TABLE 111 AI IN HEALTHCARE MARKET FOR AI SCRIBE, BY REGION,
2024–2031 (USD MILLION) 197
TABLE 112 AI IN HEALTHCARE MARKET FOR CLINICAL DECISION SUPPORT SYSTEMS,
BY REGION, 2024–2031 (USD MILLION) 198
TABLE 113 AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE,
2024–2031 (USD MILLION) 199
TABLE 114 AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY REGION,
2024–2031 (USD MILLION) 199
TABLE 115 AI IN HEALTHCARE MARKET FOR PATIENT REGISTRATION & SCHEDULING,
BY REGION, 2024–2031 (USD MILLION) 200
TABLE 116 AI IN HEALTHCARE MARKET FOR PATIENT ELIGIBILITY & AUTHORIZATION,
BY REGION, 2024–2031 (USD MILLION) 201
TABLE 117 AI IN HEALTHCARE MARKET FOR REVENUE CYCLE MANAGEMENT, BY REGION, 2024–2031 (USD MILLION) 202
TABLE 118 AI IN HEALTHCARE MARKET FOR WORKFORCE MANAGEMENT, BY REGION,
2024–2031 (USD MILLION) 203
TABLE 119 AI IN HEALTHCARE MARKET FOR SUPPLY CHAIN & INVENTORY MANAGEMENT,
BY REGION, 2024–2031 (USD MILLION) 204
TABLE 120 AI IN HEALTHCARE MARKET FOR COMPLIANCE & DOCUMENTATION, BY REGION, 2024–2031 (USD MILLION) 205
TABLE 121 AI IN HEALTHCARE MARKET FOR HEALTHCARE WORKFLOW MANAGEMENT,
BY REGION, 2024–2031 (USD MILLION) 206
TABLE 122 AI IN HEALTHCARE MARKET FOR ASSET MANAGEMENT, BY REGION,
2024–2031 (USD MILLION) 207
TABLE 123 AI IN HEALTHCARE MARKET FOR CUSTOMER RELATIONSHIP MANAGEMENT,
BY REGION, 2024–2031 (USD MILLION) 208
TABLE 124 AI IN HEALTHCARE MARKET FOR FRAUD DETECTION & RISK MANAGEMENT,
BY REGION, 2024–2031 (USD MILLION) 209
TABLE 125 AI IN HEALTHCARE MARKET FOR CYBERSECURITY, BY REGION,
2024–2031 (USD MILLION) 210
TABLE 126 AI IN HEALTHCARE MARKET FOR OTHER ADMINISTRATIVE FUNCTIONS, BY REGION, 2024–2031 (USD MILLION) 210
TABLE 127 AI IN HEALTHCARE MARKET, BY OFFERING, 2024–2031 (USD MILLION) 212
TABLE 128 AI IN HEALTHCARE MARKET FOR INTEGRATED SOLUTIONS, BY REGION,
2024–2031 (USD MILLION) 213
TABLE 129 AI IN HEALTHCARE MARKET FOR NICHE/POINT SOLUTIONS, BY REGION,
2024–2031 (USD MILLION) 214
TABLE 130 AI IN HEALTHCARE MARKET FOR AI TECHNOLOGIES, BY REGION,
2024–2031 (USD MILLION) 215
TABLE 131 AI IN HEALTHCARE MARKET FOR SERVICES, BY REGION,
2024–2031 (USD MILLION) 216
TABLE 132 AI IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 218
TABLE 133 AI IN HEALTHCARE MARKET FOR CLINICAL APPLICATIONS, BY REGION,
2024–2031 (USD MILLION) 219
TABLE 134 AI IN HEALTHCARE MARKET FOR NON-CLINICAL APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 221
TABLE 135 AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,
2024–2031 (USD MILLION) 223
TABLE 136 AI IN HEALTHCARE MARKET FOR ON-PREMISES MODEL, BY REGION,
2024–2031 (USD MILLION) 224
TABLE 137 AI IN HEALTHCARE MARKET FOR CLOUD-BASED MODEL, BY REGION,
2024–2031 (USD MILLION) 225
TABLE 138 AI IN HEALTHCARE MARKET FOR HYBRID MODEL, BY REGION,
2024–2031 (USD MILLION) 226
TABLE 139 AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 228
TABLE 140 AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE,
2024–2031 (USD MILLION) 229
TABLE 141 AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY REGION,
2024–2031 (USD MILLION) 229
TABLE 142 AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE,
2024–2031 (USD MILLION) 231
TABLE 143 AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY REGION,
2024–2031 (USD MILLION) 231
TABLE 144 AI IN HEALTHCARE MARKET FOR CONVOLUTIONAL NEURAL NETWORKS,
BY REGION, 2024–2031 (USD MILLION) 232
TABLE 145 AI IN HEALTHCARE MARKET FOR RECURRENT NEURAL NETWORKS, BY REGION, 2024–2031 (USD MILLION) 233
TABLE 146 AI IN HEALTHCARE MARKET FOR GENERATIVE ADVERSARIAL NETWORKS,
BY REGION, 2024–2031 (USD MILLION) 234
TABLE 147 AI IN HEALTHCARE MARKET FOR GRAPH NEURAL NETWORKS, BY REGION,
2024–2031 (USD MILLION) 235
TABLE 148 AI IN HEALTHCARE MARKET FOR OTHER DEEP LEARNING TOOLS, BY REGION, 2024–2031 (USD MILLION) 235
TABLE 149 AI IN HEALTHCARE MARKET FOR SUPERVISED LEARNING, BY REGION,
2024–2031 (USD MILLION) 236
TABLE 150 AI IN HEALTHCARE MARKET FOR REINFORCEMENT LEARNING, BY REGION,
2024–2031 (USD MILLION) 237
TABLE 151 AI IN HEALTHCARE MARKET FOR UNSUPERVISED LEARNING, BY REGION,
2024–2031 (USD MILLION) 238
TABLE 152 AI IN HEALTHCARE MARKET FOR OTHER MACHINE LEARNING TOOLS, BY REGION, 2024–2031 (USD MILLION) 239
TABLE 153 AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024–2031 (USD MILLION) 240
TABLE 154 AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY REGION, 2024–2031 (USD MILLION) 240
TABLE 155 AI IN HEALTHCARE MARKET FOR SENTIMENT ANALYSIS, BY REGION,
2024–2031 (USD MILLION) 241
TABLE 156 AI IN HEALTHCARE MARKET FOR PATTERN & IMAGE RECOGNITION, BY REGION, 2024–2031 (USD MILLION) 242
TABLE 157 AI IN HEALTHCARE MARKET FOR AUTO CODING, BY REGION,
2024–2031 (USD MILLION) 243
TABLE 158 AI IN HEALTHCARE MARKET FOR CLASSIFICATION & CATEGORIZATION, BY REGION, 2024–2031 (USD MILLION) 243
TABLE 159 AI IN HEALTHCARE MARKET FOR TEXT ANALYTICS, BY REGION,
2024–2031 (USD MILLION) 244
TABLE 160 AI IN HEALTHCARE MARKET FOR SPEECH RECOGNITION, BY REGION,
2024–2031 (USD MILLION) 245
TABLE 161 AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE,
2024–2031 (USD MILLION) 246
TABLE 162 AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY REGION, 2024–2031 (USD MILLION) 246
TABLE 163 AI IN HEALTHCARE MARKET FOR DEVICE CONTEXT, BY REGION,
2024–2031 (USD MILLION) 247
TABLE 164 AI IN HEALTHCARE MARKET FOR USER CONTEXT, BY REGION,
2024–2031 (USD MILLION) 248
TABLE 165 AI IN HEALTHCARE MARKET FOR PHYSICAL CONTEXT, BY REGION,
2024–2031 (USD MILLION) 248
TABLE 166 AI IN HEALTHCARE MARKET FOR GENERATIVE AI, BY REGION,
2024–2031 (USD MILLION) 249
TABLE 167 AI IN HEALTHCARE MARKET FOR COMPUTER VISION, BY REGION,
2024–2031 (USD MILLION) 250
TABLE 168 AI IN HEALTHCARE MARKET FOR IMAGE ANALYSIS, BY REGION,
2024–2031 (USD MILLION) 251
TABLE 169 AI IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 253
TABLE 170 AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE,
2024–2031 (USD MILLION) 254
TABLE 171 AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY REGION,
2024–2031 (USD MILLION) 255
TABLE 172 AI IN HEALTHCARE MARKET FOR HOSPITALS & CLINICS, BY REGION,
2024–2031 (USD MILLION) 256
TABLE 173 AI IN HEALTHCARE MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2024–2031 (USD MILLION) 257
TABLE 174 AI IN HEALTHCARE MARKET FOR HOME HEALTHCARE AGENCIES & ASSISTED-LIVING FACILITIES, BY REGION, 2024–2031 (USD MILLION) 258
TABLE 175 AI IN HEALTHCARE MARKET FOR DIAGNOSTIC & IMAGING CENTERS, BY REGION, 2024–2031 (USD MILLION) 259
TABLE 176 AI IN HEALTHCARE MARKET FOR PHARMACIES, BY REGION,
2024–2031 (USD MILLION) 260
TABLE 177 AI IN HEALTHCARE MARKET FOR OTHER HEALTHCARE PROVIDERS, BY REGION, 2024–2031 (USD MILLION) 260
TABLE 178 AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE,
2024–2031 (USD MILLION) 261
TABLE 179 AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY REGION,
2024–2031 (USD MILLION) 261
TABLE 180 AI IN HEALTHCARE MARKET FOR PUBLIC PAYERS, BY REGION,
2024–2031 (USD MILLION) 262
TABLE 181 AI IN HEALTHCARE MARKET FOR PRIVATE PAYERS, BY REGION,
2024–2031 (USD MILLION) 263
TABLE 182 AI IN HEALTHCARE MARKET FOR PATIENTS, BY REGION,
2024–2031 (USD MILLION) 264
TABLE 183 AI IN HEALTHCARE MARKET FOR OTHER END USERS, BY REGION,
2024–2031 (USD MILLION) 265
TABLE 184 AI IN HEALTHCARE MARKET, BY REGION, 2024–2031 (USD MILLION) 267
TABLE 185 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 270
TABLE 186 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY OFFERING,
2024–2031 (USD MILLION) 270
TABLE 187 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY FUNCTION,
2024–2031 (USD MILLION) 271
TABLE 188 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024–2031 (USD MILLION) 271
TABLE 189 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,
2024–2031 (USD MILLION) 272
TABLE 190 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,
2024–2031 (USD MILLION) 272
TABLE 191 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,
BY APPLICATION, 2024–2031 (USD MILLION) 273
TABLE 192 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,
BY MODALITY, 2024–2031 (USD MILLION) 273
TABLE 193 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 274
TABLE 194 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 274
TABLE 195 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 275
TABLE 196 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 275
TABLE 197 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024–2031 (USD MILLION) 276
TABLE 198 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 276
TABLE 199 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 277
TABLE 200 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 277
TABLE 201 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 278
TABLE 202 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT,
BY TYPE, 2024–2031 (USD MILLION) 278
TABLE 203 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024–2031 (USD MILLION) 279
TABLE 204 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 279
TABLE 205 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,
2024–2031 (USD MILLION) 280
TABLE 206 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY TOOL,
2024–2031 (USD MILLION) 280
TABLE 207 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024–2031 (USD MILLION) 281
TABLE 208 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024–2031 (USD MILLION) 281
TABLE 209 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024–2031 (USD MILLION) 282
TABLE 210 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 282
TABLE 211 NORTH AMERICA: AI IN HEALTHCARE MARKET, BY END USER,
2024–2031 (USD MILLION) 283
TABLE 212 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2024–2031 (USD MILLION) 283
TABLE 213 NORTH AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024–2031 (USD MILLION) 284
TABLE 214 US: AI IN HEALTHCARE MARKET, BY OFFERING, 2024–2031 (USD MILLION) 285
TABLE 215 US: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 285
TABLE 216 US: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024–2031 (USD MILLION) 286
TABLE 217 US: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,
2024–2031 (USD MILLION) 286
TABLE 218 US: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,
2024–2031 (USD MILLION) 287
TABLE 219 US: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024–2031 (USD MILLION) 287
TABLE 220 US: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY,
2024–2031 (USD MILLION) 288
TABLE 221 US: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 288
TABLE 222 US: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING,
BY TYPE, 2024–2031 (USD MILLION) 289
TABLE 223 US: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 289
TABLE 224 US: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE,
2024–2031 (USD MILLION) 290
TABLE 225 US: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE,
2024–2031 (USD MILLION) 290
TABLE 226 US: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 291
TABLE 227 US: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE,
2024–2031 (USD MILLION) 291
TABLE 228 US: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 292
TABLE 229 US: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 292
TABLE 230 US: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE,
2024–2031 (USD MILLION) 293
TABLE 231 US: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE,
2024–2031 (USD MILLION) 293
TABLE 232 US: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 294
TABLE 233 US: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,
2024–2031 (USD MILLION) 294
TABLE 234 US: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 294
TABLE 235 US: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE,
2024–2031 (USD MILLION) 295
TABLE 236 US: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE,
2024–2031 (USD MILLION) 295
TABLE 237 US: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024–2031 (USD MILLION) 296
TABLE 238 US: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 296
TABLE 239 US: AI IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 297
TABLE 240 US: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE,
2024–2031 (USD MILLION) 297
TABLE 241 US: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE,
2024–2031 (USD MILLION) 298
TABLE 242 CANADA: AI IN HEALTHCARE MARKET, BY OFFERING, 2024–2031 (USD MILLION) 299
TABLE 243 CANADA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 299
TABLE 244 CANADA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION,
BY TYPE, 2024–2031 (USD MILLION) 300
TABLE 245 CANADA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,
2024–2031 (USD MILLION) 300
TABLE 246 CANADA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,
2024–2031 (USD MILLION) 301
TABLE 247 CANADA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024–2031 (USD MILLION) 301
TABLE 248 CANADA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024–2031 (USD MILLION) 302
TABLE 249 CANADA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 302
TABLE 250 CANADA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 303
TABLE 251 CANADA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 303
TABLE 252 CANADA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE,
2024–2031 (USD MILLION) 304
TABLE 253 CANADA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE,
2024–2031 (USD MILLION) 304
TABLE 254 CANADA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 305
TABLE 255 CANADA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE,
2024–2031 (USD MILLION) 305
TABLE 256 CANADA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 306
TABLE 257 CANADA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 306
TABLE 258 CANADA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 307
TABLE 259 CANADA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE,
2024–2031 (USD MILLION) 307
TABLE 260 CANADA: AI IN HEALTHCARE MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 308
TABLE 261 CANADA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,
2024–2031 (USD MILLION) 308
TABLE 262 CANADA: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 308
TABLE 263 CANADA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE,
2024–2031 (USD MILLION) 309
TABLE 264 CANADA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE,
2024–2031 (USD MILLION) 309
TABLE 265 CANADA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING,
BY TYPE, 2024–2031 (USD MILLION) 310
TABLE 266 CANADA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 310
TABLE 267 CANADA: AI IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 311
TABLE 268 CANADA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 311
TABLE 269 CANADA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE,
2024–2031 (USD MILLION) 312
TABLE 270 EUROPE: AI IN HEALTHCARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 313
TABLE 271 EUROPE: AI IN HEALTHCARE MARKET, BY OFFERING, 2024–2031 (USD MILLION) 313
TABLE 272 EUROPE: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 314
TABLE 273 EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION,
BY TYPE, 2024–2031 (USD MILLION) 314
TABLE 274 EUROPE: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,
2024–2031 (USD MILLION) 315
TABLE 275 EUROPE: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,
2024–2031 (USD MILLION) 315
TABLE 276 EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024–2031 (USD MILLION) 316
TABLE 277 EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024–2031 (USD MILLION) 316
TABLE 278 EUROPE: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 317
TABLE 279 EUROPE: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 317
TABLE 280 EUROPE: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 318
TABLE 281 EUROPE: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE,
2024–2031 (USD MILLION) 318
TABLE 282 EUROPE: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE,
2024–2031 (USD MILLION) 319
TABLE 283 EUROPE: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 319
TABLE 284 EUROPE: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE,
2024–2031 (USD MILLION) 320
TABLE 285 EUROPE: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 320
TABLE 286 EUROPE: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 321
TABLE 287 EUROPE: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 321
TABLE 288 EUROPE: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE,
2024–2031 (USD MILLION) 322
TABLE 289 EUROPE: AI IN HEALTHCARE MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 322
TABLE 290 EUROPE: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,
2024–2031 (USD MILLION) 323
TABLE 291 EUROPE: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 323
TABLE 292 EUROPE: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE,
2024–2031 (USD MILLION) 324
TABLE 293 EUROPE: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE,
2024–2031 (USD MILLION) 324
TABLE 294 EUROPE: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING,
BY TYPE, 2024–2031 (USD MILLION) 325
TABLE 295 EUROPE: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING,
BY TYPE, 2024–2031 (USD MILLION) 325
TABLE 296 EUROPE: AI IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 326
TABLE 297 EUROPE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 326
TABLE 298 EUROPE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE,
2024–2031 (USD MILLION) 327
TABLE 299 GERMANY: AI IN HEALTHCARE MARKET, BY OFFERING, 2024–2031 (USD MILLION) 328
TABLE 300 GERMANY: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 328
TABLE 301 GERMANY: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION,
BY TYPE, 2024–2031 (USD MILLION) 329
TABLE 302 GERMANY: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,
2024–2031 (USD MILLION) 329
TABLE 303 GERMANY: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,
2024–2031 (USD MILLION) 330
TABLE 304 GERMANY: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,
BY APPLICATION, 2024–2031 (USD MILLION) 330
TABLE 305 GERMANY: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024–2031 (USD MILLION) 331
TABLE 306 GERMANY: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 331
TABLE 307 GERMANY: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 332
TABLE 308 GERMANY: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY,
BY TYPE, 2024–2031 (USD MILLION) 332
TABLE 309 GERMANY: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE,
2024–2031 (USD MILLION) 333
TABLE 310 GERMANY: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024–2031 (USD MILLION) 333
TABLE 311 GERMANY: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 334
TABLE 312 GERMANY: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE,
2024–2031 (USD MILLION) 334
TABLE 313 GERMANY: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 335
TABLE 314 GERMANY: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 335
TABLE 315 GERMANY: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 336
TABLE 316 GERMANY: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE,
2024–2031 (USD MILLION) 336
TABLE 317 GERMANY: AI IN HEALTHCARE MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 337
TABLE 318 GERMANY: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,
2024–2031 (USD MILLION) 337
TABLE 319 GERMANY: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 337
TABLE 320 GERMANY: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024–2031 (USD MILLION) 338
TABLE 321 GERMANY: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE,
2024–2031 (USD MILLION) 338
TABLE 322 GERMANY: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024–2031 (USD MILLION) 339
TABLE 323 GERMANY: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING,
BY TYPE, 2024–2031 (USD MILLION) 339
TABLE 324 GERMANY: AI IN HEALTHCARE MARKET, BY END USER,
2024–2031 (USD MILLION) 339
TABLE 325 GERMANY: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 340
TABLE 326 GERMANY: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024–2031 (USD MILLION) 340
TABLE 327 UK: AI IN HEALTHCARE MARKET, BY OFFERING, 2024–2031 (USD MILLION) 341
TABLE 328 UK: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 342
TABLE 329 UK: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024–2031 (USD MILLION) 342
TABLE 330 UK: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,
2024–2031 (USD MILLION) 343
TABLE 331 UK: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,
2024–2031 (USD MILLION) 343
TABLE 332 UK: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024–2031 (USD MILLION) 343
TABLE 333 UK: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY,
2024–2031 (USD MILLION) 344
TABLE 334 UK: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 344
TABLE 335 UK: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING,
BY TYPE, 2024–2031 (USD MILLION) 345
TABLE 336 UK: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 345
TABLE 337 UK: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE,
2024–2031 (USD MILLION) 346
TABLE 338 UK: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE,
2024–2031 (USD MILLION) 346
TABLE 339 UK: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 347
TABLE 340 UK: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE,
2024–2031 (USD MILLION) 347
TABLE 341 UK: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 348
TABLE 342 UK: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 348
TABLE 343 UK: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE,
2024–2031 (USD MILLION) 349
TABLE 344 UK: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE,
2024–2031 (USD MILLION) 349
TABLE 345 UK: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 350
TABLE 346 UK: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,
2024–2031 (USD MILLION) 350
TABLE 347 UK: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 350
TABLE 348 UK: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE,
2024–2031 (USD MILLION) 351
TABLE 349 UK: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE,
2024–2031 (USD MILLION) 351
TABLE 350 UK: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024–2031 (USD MILLION) 352
TABLE 351 UK: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 352
TABLE 352 UK: AI IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 353
TABLE 353 UK: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE,
2024–2031 (USD MILLION) 353
TABLE 354 UK: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE,
2024–2031 (USD MILLION) 354
TABLE 355 FRANCE: AI IN HEALTHCARE MARKET, BY OFFERING, 2024–2031 (USD MILLION) 355
TABLE 356 FRANCE: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 355
TABLE 357 FRANCE: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION,
BY TYPE, 2024–2031 (USD MILLION) 356
TABLE 358 FRANCE: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,
2024–2031 (USD MILLION) 356
TABLE 359 FRANCE: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,
2024–2031 (USD MILLION) 357
TABLE 360 FRANCE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,
BY APPLICATION, 2024–2031 (USD MILLION) 357
TABLE 361 FRANCE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024–2031 (USD MILLION) 358
TABLE 362 FRANCE: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 358
TABLE 363 FRANCE: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 359
TABLE 364 FRANCE: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 359
TABLE 365 FRANCE: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE,
2024–2031 (USD MILLION) 360
TABLE 366 FRANCE: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE,
2024–2031 (USD MILLION) 360
TABLE 367 FRANCE: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 361
TABLE 368 FRANCE: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 361
TABLE 369 FRANCE: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 362
TABLE 370 FRANCE: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 362
TABLE 371 FRANCE: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 363
TABLE 372 FRANCE: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE,
2024–2031 (USD MILLION) 363
TABLE 373 FRANCE: AI IN HEALTHCARE MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 364
TABLE 374 FRANCE: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,
2024–2031 (USD MILLION) 364
TABLE 375 FRANCE: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 364
TABLE 376 FRANCE: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE,
2024–2031 (USD MILLION) 365
TABLE 377 FRANCE: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE,
2024–2031 (USD MILLION) 365
TABLE 378 FRANCE: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING,
BY TYPE, 2024–2031 (USD MILLION) 366
TABLE 379 FRANCE: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 366
TABLE 380 FRANCE: AI IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 367
TABLE 381 FRANCE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 367
TABLE 382 FRANCE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE,
2024–2031 (USD MILLION) 368
TABLE 383 ITALY: AI IN HEALTHCARE MARKET, BY OFFERING, 2024–2031 (USD MILLION) 369
TABLE 384 ITALY: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 369
TABLE 385 ITALY: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024–2031 (USD MILLION) 370
TABLE 386 ITALY: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,
2024–2031 (USD MILLION) 370
TABLE 387 ITALY: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,
2024–2031 (USD MILLION) 371
TABLE 388 ITALY: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024–2031 (USD MILLION) 371
TABLE 389 ITALY: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024–2031 (USD MILLION) 372
TABLE 390 ITALY: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 372
TABLE 391 ITALY: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 373
TABLE 392 ITALY: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 373
TABLE 393 ITALY: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE,
2024–2031 (USD MILLION) 374
TABLE 394 ITALY: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE,
2024–2031 (USD MILLION) 374
TABLE 395 ITALY: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 375
TABLE 396 ITALY: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE,
2024–2031 (USD MILLION) 375
TABLE 397 ITALY: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 376
TABLE 398 ITALY: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 376
TABLE 399 ITALY: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 377
TABLE 400 ITALY: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE,
2024–2031 (USD MILLION) 377
TABLE 401 ITALY: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 378
TABLE 402 ITALY: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,
2024–2031 (USD MILLION) 378
TABLE 403 ITALY: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 378
TABLE 404 ITALY: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE,
2024–2031 (USD MILLION) 379
TABLE 405 ITALY: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE,
2024–2031 (USD MILLION) 379
TABLE 406 ITALY: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING,
BY TYPE, 2024–2031 (USD MILLION) 380
TABLE 407 ITALY: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 380
TABLE 408 ITALY: AI IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 381
TABLE 409 ITALY: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 381
TABLE 410 ITALY: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE,
2024–2031 (USD MILLION) 382
TABLE 411 SPAIN: AI IN HEALTHCARE MARKET, BY OFFERING, 2024–2031 (USD MILLION) 383
TABLE 412 SPAIN: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 383
TABLE 413 SPAIN: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION,
BY TYPE, 2024–2031 (USD MILLION) 384
TABLE 414 SPAIN: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,
2024–2031 (USD MILLION) 384
TABLE 415 SPAIN: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,
2024–2031 (USD MILLION) 385
TABLE 416 SPAIN: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024–2031 (USD MILLION) 385
TABLE 417 SPAIN: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024–2031 (USD MILLION) 386
TABLE 418 SPAIN: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 386
TABLE 419 SPAIN: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 387
TABLE 420 SPAIN: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 387
TABLE 421 SPAIN: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE,
2024–2031 (USD MILLION) 388
TABLE 422 SPAIN: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE,
2024–2031 (USD MILLION) 388
TABLE 423 SPAIN: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 389
TABLE 424 SPAIN: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE,
2024–2031 (USD MILLION) 389
TABLE 425 SPAIN: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 390
TABLE 426 SPAIN: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 390
TABLE 427 SPAIN: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 391
TABLE 428 SPAIN: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE,
2024–2031 (USD MILLION) 391
TABLE 429 SPAIN: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 392
TABLE 430 SPAIN: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,
2024–2031 (USD MILLION) 392
TABLE 431 SPAIN: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 392
TABLE 432 SPAIN: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE,
2024–2031 (USD MILLION) 393
TABLE 433 SPAIN: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE,
2024–2031 (USD MILLION) 393
TABLE 434 SPAIN: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING,
BY TYPE, 2024–2031 (USD MILLION) 394
TABLE 435 SPAIN: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 394
TABLE 436 SPAIN: AI IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 394
TABLE 437 SPAIN: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 395
TABLE 438 SPAIN: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE,
2024–2031 (USD MILLION) 395
TABLE 439 REST OF EUROPE: AI IN HEALTHCARE MARKET, BY OFFERING,
2024–2031 (USD MILLION) 396
TABLE 440 REST OF EUROPE: AI IN HEALTHCARE MARKET, BY FUNCTION,
2024–2031 (USD MILLION) 397
TABLE 441 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024–2031 (USD MILLION) 397
TABLE 442 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,
2024–2031 (USD MILLION) 398
TABLE 443 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,
2024–2031 (USD MILLION) 398
TABLE 444 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,
BY APPLICATION, 2024–2031 (USD MILLION) 399
TABLE 445 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,
BY MODALITY, 2024–2031 (USD MILLION) 399
TABLE 446 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 400
TABLE 447 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 400
TABLE 448 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 401
TABLE 449 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 401
TABLE 450 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024–2031 (USD MILLION) 402
TABLE 451 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 402
TABLE 452 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 403
TABLE 453 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 403
TABLE 454 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 404
TABLE 455 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT,
BY TYPE, 2024–2031 (USD MILLION) 404
TABLE 456 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024–2031 (USD MILLION) 405
TABLE 457 REST OF EUROPE: AI IN HEALTHCARE MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 405
TABLE 458 REST OF EUROPE: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,
2024–2031 (USD MILLION) 406
TABLE 459 REST OF EUROPE: AI IN HEALTHCARE MARKET, BY TOOL,
2024–2031 (USD MILLION) 406
TABLE 460 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024–2031 (USD MILLION) 407
TABLE 461 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024–2031 (USD MILLION) 407
TABLE 462 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024–2031 (USD MILLION) 408
TABLE 463 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 408
TABLE 464 REST OF EUROPE: AI IN HEALTHCARE MARKET, BY END USER,
2024–2031 (USD MILLION) 409
TABLE 465 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2024–2031 (USD MILLION) 409
TABLE 466 REST OF EUROPE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS,
BY TYPE, 2024–2031 (USD MILLION) 410
TABLE 467 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 412
TABLE 468 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY OFFERING,
2024–2031 (USD MILLION) 412
TABLE 469 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY FUNCTION,
2024–2031 (USD MILLION) 413
TABLE 470 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024–2031 (USD MILLION) 413
TABLE 471 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,
2024–2031 (USD MILLION) 414
TABLE 472 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,
2024–2031 (USD MILLION) 414
TABLE 473 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,
BY APPLICATION, 2024–2031 (USD MILLION) 414
TABLE 474 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,
BY MODALITY, 2024–2031 (USD MILLION) 415
TABLE 475 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 415
TABLE 476 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 416
TABLE 477 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY,
BY TYPE, 2024–2031 (USD MILLION) 416
TABLE 478 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 417
TABLE 479 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024–2031 (USD MILLION) 417
TABLE 480 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 418
TABLE 481 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 418
TABLE 482 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 419
TABLE 483 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 419
TABLE 484 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT,
BY TYPE, 2024–2031 (USD MILLION) 420
TABLE 485 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE,
2024–2031 (USD MILLION) 420
TABLE 486 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 421
TABLE 487 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,
2024–2031 (USD MILLION) 421
TABLE 488 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 421
TABLE 489 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024–2031 (USD MILLION) 422
TABLE 490 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE,
2024–2031 (USD MILLION) 422
TABLE 491 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024–2031 (USD MILLION) 423
TABLE 492 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING,
BY TYPE, 2024–2031 (USD MILLION) 423
TABLE 493 ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY END USER,
2024–2031 (USD MILLION) 423
TABLE 494 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2024–2031 (USD MILLION) 424
TABLE 495 ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024–2031 (USD MILLION) 424
TABLE 496 CHINA: AI IN HEALTHCARE MARKET, BY OFFERING, 2024–2031 (USD MILLION) 425
TABLE 497 CHINA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 426
TABLE 498 CHINA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION,
BY TYPE, 2024–2031 (USD MILLION) 426
TABLE 499 CHINA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,
2024–2031 (USD MILLION) 427
TABLE 500 CHINA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,
2024–2031 (USD MILLION) 427
TABLE 501 CHINA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024–2031 (USD MILLION) 427
TABLE 502 CHINA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024–2031 (USD MILLION) 428
TABLE 503 CHINA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 428
TABLE 504 CHINA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 429
TABLE 505 CHINA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 429
TABLE 506 CHINA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE,
2024–2031 (USD MILLION) 430
TABLE 507 CHINA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE,
2024–2031 (USD MILLION) 430
TABLE 508 CHINA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 431
TABLE 509 CHINA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE,
2024–2031 (USD MILLION) 431
TABLE 510 CHINA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 432
TABLE 511 CHINA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 432
TABLE 512 CHINA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 433
TABLE 513 CHINA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE,
2024–2031 (USD MILLION) 433
TABLE 514 CHINA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 434
TABLE 515 CHINA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,
2024–2031 (USD MILLION) 434
TABLE 516 CHINA: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 434
TABLE 517 CHINA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE,
2024–2031 (USD MILLION) 435
TABLE 518 CHINA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE,
2024–2031 (USD MILLION) 435
TABLE 519 CHINA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING,
BY TYPE, 2024–2031 (USD MILLION) 436
TABLE 520 CHINA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 436
TABLE 521 CHINA: AI IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 437
TABLE 522 CHINA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 437
TABLE 523 CHINA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE,
2024–2031 (USD MILLION) 437
TABLE 524 JAPAN: AI IN HEALTHCARE MARKET, BY OFFERING, 2024–2031 (USD MILLION) 438
TABLE 525 JAPAN: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 439
TABLE 526 JAPAN: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION,
BY TYPE, 2024–2031 (USD MILLION) 439
TABLE 527 JAPAN: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,
2024–2031 (USD MILLION) 440
TABLE 528 JAPAN: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,
2024–2031 (USD MILLION) 440
TABLE 529 JAPAN: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024–2031 (USD MILLION) 440
TABLE 530 JAPAN: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024–2031 (USD MILLION) 441
TABLE 531 JAPAN: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 441
TABLE 532 JAPAN: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 442
TABLE 533 JAPAN: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 442
TABLE 534 JAPAN: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE,
2024–2031 (USD MILLION) 443
TABLE 535 JAPAN: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE,
2024–2031 (USD MILLION) 443
TABLE 536 JAPAN: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 444
TABLE 537 JAPAN: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE,
2024–2031 (USD MILLION) 444
TABLE 538 JAPAN: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 445
TABLE 539 JAPAN: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 445
TABLE 540 JAPAN: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 446
TABLE 541 JAPAN: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE,
2024–2031 (USD MILLION) 446
TABLE 542 JAPAN: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 447
TABLE 543 JAPAN: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,
2024–2031 (USD MILLION) 447
TABLE 544 JAPAN: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 447
TABLE 545 JAPAN: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE,
2024–2031 (USD MILLION) 448
TABLE 546 JAPAN: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE,
2024–2031 (USD MILLION) 448
TABLE 547 JAPAN: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING,
BY TYPE, 2024–2031 (USD MILLION) 449
TABLE 548 JAPAN: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 449
TABLE 549 JAPAN: AI IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 449
TABLE 550 JAPAN: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 450
TABLE 551 JAPAN: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE,
2024–2031 (USD MILLION) 450
TABLE 552 INDIA: AI IN HEALTHCARE MARKET, BY OFFERING, 2024–2031 (USD MILLION) 452
TABLE 553 INDIA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 452
TABLE 554 INDIA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024–2031 (USD MILLION) 453
TABLE 555 INDIA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,
2024–2031 (USD MILLION) 453
TABLE 556 INDIA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,
2024–2031 (USD MILLION) 454
TABLE 557 INDIA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024–2031 (USD MILLION) 454
TABLE 558 INDIA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024–2031 (USD MILLION) 455
TABLE 559 INDIA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 455
TABLE 560 INDIA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 456
TABLE 561 INDIA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 456
TABLE 562 INDIA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE,
2024–2031 (USD MILLION) 457
TABLE 563 INDIA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE,
2024–2031 (USD MILLION) 457
TABLE 564 INDIA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 458
TABLE 565 INDIA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE,
2024–2031 (USD MILLION) 458
TABLE 566 INDIA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 459
TABLE 567 INDIA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 459
TABLE 568 INDIA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 460
TABLE 569 INDIA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE,
2024–2031 (USD MILLION) 460
TABLE 570 INDIA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 461
TABLE 571 INDIA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,
2024–2031 (USD MILLION) 461
TABLE 572 INDIA: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 461
TABLE 573 INDIA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE,
2024–2031 (USD MILLION) 462
TABLE 574 INDIA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE,
2024–2031 (USD MILLION) 462
TABLE 575 INDIA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING,
BY TYPE, 2024–2031 (USD MILLION) 463
TABLE 576 INDIA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 463
TABLE 577 INDIA: AI IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 463
TABLE 578 INDIA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 464
TABLE 579 INDIA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE,
2024–2031 (USD MILLION) 464
TABLE 580 AUSTRALIA: AI IN HEALTHCARE MARKET, BY OFFERING,
2024–2031 (USD MILLION) 465
TABLE 581 AUSTRALIA: AI IN HEALTHCARE MARKET, BY FUNCTION,
2024–2031 (USD MILLION) 466
TABLE 582 AUSTRALIA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION,
BY TYPE, 2024–2031 (USD MILLION) 466
TABLE 583 AUSTRALIA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,
2024–2031 (USD MILLION) 467
TABLE 584 AUSTRALIA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,
2024–2031 (USD MILLION) 467
TABLE 585 AUSTRALIA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,
BY APPLICATION, 2024–2031 (USD MILLION) 467
TABLE 586 AUSTRALIA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024–2031 (USD MILLION) 468
TABLE 587 AUSTRALIA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 468
TABLE 588 AUSTRALIA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 469
TABLE 589 AUSTRALIA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY,
BY TYPE, 2024–2031 (USD MILLION) 469
TABLE 590 AUSTRALIA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE,
2024–2031 (USD MILLION) 470
TABLE 591 AUSTRALIA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024–2031 (USD MILLION) 470
TABLE 592 AUSTRALIA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 471
TABLE 593 AUSTRALIA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE,
2024–2031 (USD MILLION) 471
TABLE 594 AUSTRALIA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 472
TABLE 595 AUSTRALIA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 472
TABLE 596 AUSTRALIA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 473
TABLE 597 AUSTRALIA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE,
2024–2031 (USD MILLION) 473
TABLE 598 AUSTRALIA: AI IN HEALTHCARE MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 474
TABLE 599 AUSTRALIA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,
2024–2031 (USD MILLION) 474
TABLE 600 AUSTRALIA: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 474
TABLE 601 AUSTRALIA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024–2031 (USD MILLION) 475
TABLE 602 AUSTRALIA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE,
2024–2031 (USD MILLION) 475
TABLE 603 AUSTRALIA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024–2031 (USD MILLION) 476
TABLE 604 AUSTRALIA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING,
BY TYPE, 2024–2031 (USD MILLION) 476
TABLE 605 AUSTRALIA: AI IN HEALTHCARE MARKET, BY END USER,
2024–2031 (USD MILLION) 476
TABLE 606 AUSTRALIA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 477
TABLE 607 AUSTRALIA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024–2031 (USD MILLION) 477
TABLE 608 SOUTH KOREA: AI IN HEALTHCARE MARKET, BY OFFERING,
2024–2031 (USD MILLION) 478
TABLE 609 SOUTH KOREA: AI IN HEALTHCARE MARKET, BY FUNCTION,
2024–2031 (USD MILLION) 479
TABLE 610 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024–2031 (USD MILLION) 479
TABLE 611 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,
2024–2031 (USD MILLION) 480
TABLE 612 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,
2024–2031 (USD MILLION) 480
TABLE 613 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,
BY APPLICATION, 2024–2031 (USD MILLION) 480
TABLE 614 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,
BY MODALITY, 2024–2031 (USD MILLION) 481
TABLE 615 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 481
TABLE 616 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 482
TABLE 617 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY,
BY TYPE, 2024–2031 (USD MILLION) 482
TABLE 618 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 483
TABLE 619 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024–2031 (USD MILLION) 483
TABLE 620 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 484
TABLE 621 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 484
TABLE 622 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 485
TABLE 623 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 485
TABLE 624 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT,
BY TYPE, 2024–2031 (USD MILLION) 486
TABLE 625 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024–2031 (USD MILLION) 486
TABLE 626 SOUTH KOREA: AI IN HEALTHCARE MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 487
TABLE 627 SOUTH KOREA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,
2024–2031 (USD MILLION) 487
TABLE 628 SOUTH KOREA: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 487
TABLE 629 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024–2031 (USD MILLION) 488
TABLE 630 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024–2031 (USD MILLION) 488
TABLE 631 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024–2031 (USD MILLION) 489
TABLE 632 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING,
BY TYPE, 2024–2031 (USD MILLION) 489
TABLE 633 SOUTH KOREA: AI IN HEALTHCARE MARKET, BY END USER,
2024–2031 (USD MILLION) 489
TABLE 634 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2024–2031 (USD MILLION) 490
TABLE 635 SOUTH KOREA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024–2031 (USD MILLION) 490
TABLE 636 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY OFFERING,
2024–2031 (USD MILLION) 491
TABLE 637 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY FUNCTION,
2024–2031 (USD MILLION) 492
TABLE 638 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024–2031 (USD MILLION) 492
TABLE 639 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024–2031 (USD MILLION) 493
TABLE 640 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024–2031 (USD MILLION) 493
TABLE 641 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,
BY APPLICATION, 2024–2031 (USD MILLION) 493
TABLE 642 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,
BY MODALITY, 2024–2031 (USD MILLION) 494
TABLE 643 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 494
TABLE 644 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 495
TABLE 645 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 495
TABLE 646 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY,
BY TYPE, 2024–2031 (USD MILLION) 496
TABLE 647 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY,
BY TYPE, 2024–2031 (USD MILLION) 496
TABLE 648 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 497
TABLE 649 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY,
BY TYPE, 2024–2031 (USD MILLION) 497
TABLE 650 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 498
TABLE 651 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 498
TABLE 652 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 499
TABLE 653 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE,
BY TYPE, 2024–2031 (USD MILLION) 499
TABLE 654 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 500
TABLE 655 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 500
TABLE 656 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY TOOL,
2024–2031 (USD MILLION) 500
TABLE 657 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING,
BY TYPE, 2024–2031 (USD MILLION) 501
TABLE 658 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024–2031 (USD MILLION) 501
TABLE 659 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024–2031 (USD MILLION) 502
TABLE 660 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 502
TABLE 661 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET, BY END USER,
2024–2031 (USD MILLION) 503
TABLE 662 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 503
TABLE 663 REST OF ASIA PACIFIC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS,
BY TYPE, 2024–2031 (USD MILLION) 503
TABLE 664 LATIN AMERICA: AI IN HEALTHCARE MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 505
TABLE 665 LATIN AMERICA: AI IN HEALTHCARE MARKET, BY OFFERING,
2024–2031 (USD MILLION) 505
TABLE 666 LATIN AMERICA: AI IN HEALTHCARE MARKET, BY FUNCTION,
2024–2031 (USD MILLION) 506
TABLE 667 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024–2031 (USD MILLION) 506
TABLE 668 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,
2024–2031 (USD MILLION) 507
TABLE 669 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,
2024–2031 (USD MILLION) 507
TABLE 670 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,
BY APPLICATION, 2024–2031 (USD MILLION) 507
TABLE 671 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,
BY MODALITY, 2024–2031 (USD MILLION) 508
TABLE 672 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 508
TABLE 673 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 509
TABLE 674 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 509
TABLE 675 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 510
TABLE 676 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024–2031 (USD MILLION) 510
TABLE 677 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 511
TABLE 678 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 511
TABLE 679 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 512
TABLE 680 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 512
TABLE 681 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT,
BY TYPE, 2024–2031 (USD MILLION) 513
TABLE 682 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024–2031 (USD MILLION) 513
TABLE 683 LATIN AMERICA: AI IN HEALTHCARE MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 514
TABLE 684 LATIN AMERICA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,
2024–2031 (USD MILLION) 514
TABLE 685 LATIN AMERICA: AI IN HEALTHCARE MARKET, BY TOOL,
2024–2031 (USD MILLION) 514
TABLE 686 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024–2031 (USD MILLION) 515
TABLE 687 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024–2031 (USD MILLION) 515
TABLE 688 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024–2031 (USD MILLION) 516
TABLE 689 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 516
TABLE 690 LATIN AMERICA: AI IN HEALTHCARE MARKET, BY END USER,
2024–2031 (USD MILLION) 516
TABLE 691 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2024–2031 (USD MILLION) 517
TABLE 692 LATIN AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024–2031 (USD MILLION) 517
TABLE 693 BRAZIL: AI IN HEALTHCARE MARKET, BY OFFERING, 2024–2031 (USD MILLION) 518
TABLE 694 BRAZIL: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 519
TABLE 695 BRAZIL: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION,
BY TYPE, 2024–2031 (USD MILLION) 519
TABLE 696 BRAZIL: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,
2024–2031 (USD MILLION) 520
TABLE 697 BRAZIL: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,
2024–2031 (USD MILLION) 520
TABLE 698 BRAZIL: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024–2031 (USD MILLION) 520
TABLE 699 BRAZIL: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024–2031 (USD MILLION) 521
TABLE 700 BRAZIL: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 521
TABLE 701 BRAZIL: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 522
TABLE 702 BRAZIL: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 522
TABLE 703 BRAZIL: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE,
2024–2031 (USD MILLION) 523
TABLE 704 BRAZIL: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE,
2024–2031 (USD MILLION) 523
TABLE 705 BRAZIL: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 524
TABLE 706 BRAZIL: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE,
2024–2031 (USD MILLION) 524
TABLE 707 BRAZIL: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 525
TABLE 708 BRAZIL: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 525
TABLE 709 BRAZIL: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 526
TABLE 710 BRAZIL: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE,
2024–2031 (USD MILLION) 526
TABLE 711 BRAZIL: AI IN HEALTHCARE MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 527
TABLE 712 BRAZIL: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,
2024–2031 (USD MILLION) 527
TABLE 713 BRAZIL: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 527
TABLE 714 BRAZIL: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE,
2024–2031 (USD MILLION) 528
TABLE 715 BRAZIL: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE,
2024–2031 (USD MILLION) 528
TABLE 716 BRAZIL: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING,
BY TYPE, 2024–2031 (USD MILLION) 529
TABLE 717 BRAZIL: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 529
TABLE 718 BRAZIL: AI IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 529
TABLE 719 BRAZIL: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 530
TABLE 720 BRAZIL: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE,
2024–2031 (USD MILLION) 530
TABLE 721 MEXICO: AI IN HEALTHCARE MARKET, BY OFFERING, 2024–2031 (USD MILLION) 531
TABLE 722 MEXICO: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 532
TABLE 723 MEXICO: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION,
BY TYPE, 2024–2031 (USD MILLION) 532
TABLE 724 MEXICO: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,
2024–2031 (USD MILLION) 533
TABLE 725 MEXICO: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,
2024–2031 (USD MILLION) 533
TABLE 726 MEXICO: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024–2031 (USD MILLION) 533
TABLE 727 MEXICO: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024–2031 (USD MILLION) 534
TABLE 728 MEXICO: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 534
TABLE 729 MEXICO: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 535
TABLE 730 MEXICO: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 535
TABLE 731 MEXICO: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE,
2024–2031 (USD MILLION) 536
TABLE 732 MEXICO: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE,
2024–2031 (USD MILLION) 536
TABLE 733 MEXICO: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 537
TABLE 734 MEXICO: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE,
2024–2031 (USD MILLION) 537
TABLE 735 MEXICO: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 538
TABLE 736 MEXICO: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 538
TABLE 737 MEXICO: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 539
TABLE 738 MEXICO: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE,
2024–2031 (USD MILLION) 539
TABLE 739 MEXICO: AI IN HEALTHCARE MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 540
TABLE 740 MEXICO: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,
2024–2031 (USD MILLION) 540
TABLE 741 MEXICO: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 540
TABLE 742 MEXICO: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE,
2024–2031 (USD MILLION) 541
TABLE 743 MEXICO: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE,
2024–2031 (USD MILLION) 541
TABLE 744 MEXICO: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING,
BY TYPE, 2024–2031 (USD MILLION) 542
TABLE 745 MEXICO: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 542
TABLE 746 MEXICO: AI IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 542
TABLE 747 MEXICO: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 543
TABLE 748 MEXICO: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE,
2024–2031 (USD MILLION) 543
TABLE 749 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY OFFERING,
2024–2031 (USD MILLION) 544
TABLE 750 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY FUNCTION,
2024–2031 (USD MILLION) 545
TABLE 751 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024–2031 (USD MILLION) 545
TABLE 752 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024–2031 (USD MILLION) 546
TABLE 753 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024–2031 (USD MILLION) 546
TABLE 754 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024–2031 (USD MILLION) 546
TABLE 755 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024–2031 (USD MILLION) 547
TABLE 756 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 547
TABLE 757 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 548
TABLE 758 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 548
TABLE 759 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY,
BY TYPE, 2024–2031 (USD MILLION) 549
TABLE 760 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024–2031 (USD MILLION) 549
TABLE 761 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 550
TABLE 762 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY,
BY TYPE, 2024–2031 (USD MILLION) 550
TABLE 763 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 551
TABLE 764 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 551
TABLE 765 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 552
TABLE 766 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE,
BY TYPE, 2024–2031 (USD MILLION) 552
TABLE 767 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 553
TABLE 768 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 553
TABLE 769 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY TOOL,
2024–2031 (USD MILLION) 553
TABLE 770 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024–2031 (USD MILLION) 554
TABLE 771 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING,
BY TYPE, 2024–2031 (USD MILLION) 554
TABLE 772 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024–2031 (USD MILLION) 555
TABLE 773 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 555
TABLE 774 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET, BY END USER,
2024–2031 (USD MILLION) 555
TABLE 775 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 556
TABLE 776 REST OF LATIN AMERICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024–2031 (USD MILLION) 556
TABLE 777 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 557
TABLE 778 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY OFFERING,
2024–2031 (USD MILLION) 558
TABLE 779 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY FUNCTION,
2024–2031 (USD MILLION) 558
TABLE 780 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024–2031 (USD MILLION) 559
TABLE 781 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY, 2024–2031 (USD MILLION) 559
TABLE 782 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION, 2024–2031 (USD MILLION) 560
TABLE 783 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024–2031 (USD MILLION) 560
TABLE 784 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024–2031 (USD MILLION) 561
TABLE 785 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 561
TABLE 786 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 562
TABLE 787 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 562
TABLE 788 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY,
BY TYPE, 2024–2031 (USD MILLION) 563
TABLE 789 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY,
BY TYPE, 2024–2031 (USD MILLION) 563
TABLE 790 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 564
TABLE 791 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY,
BY TYPE, 2024–2031 (USD MILLION) 564
TABLE 792 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 565
TABLE 793 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 565
TABLE 794 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 566
TABLE 795 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE,
BY TYPE, 2024–2031 (USD MILLION) 566
TABLE 796 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 567
TABLE 797 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 567
TABLE 798 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY TOOL,
2024–2031 (USD MILLION) 567
TABLE 799 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING,
BY TYPE, 2024–2031 (USD MILLION) 568
TABLE 800 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING,
BY TYPE, 2024–2031 (USD MILLION) 568
TABLE 801 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024–2031 (USD MILLION) 569
TABLE 802 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 569
TABLE 803 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY END USER,
2024–2031 (USD MILLION) 569
TABLE 804 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 570
TABLE 805 MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024–2031 (USD MILLION) 570
TABLE 806 GCC: AI IN HEALTHCARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 571
TABLE 807 GCC: AI IN HEALTHCARE MARKET, BY OFFERING, 2024–2031 (USD MILLION) 571
TABLE 808 GCC: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 572
TABLE 809 GCC: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024–2031 (USD MILLION) 572
TABLE 810 GCC: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,
2024–2031 (USD MILLION) 573
TABLE 811 GCC: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,
2024–2031 (USD MILLION) 573
TABLE 812 GCC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024–2031 (USD MILLION) 573
TABLE 813 GCC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024–2031 (USD MILLION) 574
TABLE 814 GCC: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 574
TABLE 815 GCC: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING,
BY TYPE, 2024–2031 (USD MILLION) 575
TABLE 816 GCC: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 575
TABLE 817 GCC: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE,
2024–2031 (USD MILLION) 576
TABLE 818 GCC: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE,
2024–2031 (USD MILLION) 576
TABLE 819 GCC: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 577
TABLE 820 GCC: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE,
2024–2031 (USD MILLION) 577
TABLE 821 GCC: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 578
TABLE 822 GCC: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 578
TABLE 823 GCC: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 579
TABLE 824 GCC: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE,
2024–2031 (USD MILLION) 579
TABLE 825 GCC COUNTRIES: AI IN HEALTHCARE MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 580
TABLE 826 GCC: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,
2024–2031 (USD MILLION) 580
TABLE 827 GCC: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 580
TABLE 828 GCC: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE,
2024–2031 (USD MILLION) 581
TABLE 829 GCC: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE,
2024–2031 (USD MILLION) 581
TABLE 830 GCC: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING,
BY TYPE, 2024–2031 (USD MILLION) 582
TABLE 831 GCC: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 582
TABLE 832 GCC: AI IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 582
TABLE 833 GCC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE,
2024–2031 (USD MILLION) 583
TABLE 834 GCC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE,
2024–2031 (USD MILLION) 583
TABLE 835 SAUDI ARABIA: AI IN HEALTHCARE MARKET, BY OFFERING,
2024–2031 (USD MILLION) 584
TABLE 836 SAUDI ARABIA: AI IN HEALTHCARE MARKET, BY FUNCTION,
2024–2031 (USD MILLION) 584
TABLE 837 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024–2031 (USD MILLION) 585
TABLE 838 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,
2024–2031 (USD MILLION) 585
TABLE 839 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,
2024–2031 (USD MILLION) 586
TABLE 840 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,
BY APPLICATION, 2024–2031 (USD MILLION) 586
TABLE 841 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,
BY MODALITY, 2024–2031 (USD MILLION) 587
TABLE 842 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 587
TABLE 843 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 588
TABLE 844 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY,
BY TYPE, 2024–2031 (USD MILLION) 588
TABLE 845 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 589
TABLE 846 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024–2031 (USD MILLION) 589
TABLE 847 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 590
TABLE 848 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 590
TABLE 849 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 591
TABLE 850 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 591
TABLE 851 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT,
BY TYPE, 2024–2031 (USD MILLION) 592
TABLE 852 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024–2031 (USD MILLION) 592
TABLE 853 SAUDI ARABIA: AI IN HEALTHCARE MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 593
TABLE 854 SAUDI ARABIA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,
2024–2031 (USD MILLION) 593
TABLE 855 SAUDI ARABIA: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 593
TABLE 856 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024–2031 (USD MILLION) 594
TABLE 857 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE,
2024–2031 (USD MILLION) 594
TABLE 858 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024–2031 (USD MILLION) 595
TABLE 859 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING,
BY TYPE, 2024–2031 (USD MILLION) 595
TABLE 860 SAUDI ARABIA: AI IN HEALTHCARE MARKET, BY END USER,
2024–2031 (USD MILLION) 595
TABLE 861 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2024–2031 (USD MILLION) 596
TABLE 862 SAUDI ARABIA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024–2031 (USD MILLION) 596
TABLE 863 UAE: AI IN HEALTHCARE MARKET, BY OFFERING, 2024–2031 (USD MILLION) 597
TABLE 864 UAE: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 598
TABLE 865 UAE: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024–2031 (USD MILLION) 598
TABLE 866 UAE: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,
2024–2031 (USD MILLION) 599
TABLE 867 UAE: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,
2024–2031 (USD MILLION) 599
TABLE 868 UAE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024–2031 (USD MILLION) 599
TABLE 869 UAE: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024–2031 (USD MILLION) 600
TABLE 870 UAE: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 600
TABLE 871 UAE: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING,
BY TYPE, 2024–2031 (USD MILLION) 601
TABLE 872 UAE: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 601
TABLE 873 UAE: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE,
2024–2031 (USD MILLION) 602
TABLE 874 UAE: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE,
2024–2031 (USD MILLION) 602
TABLE 875 UAE: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 603
TABLE 876 UAE: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE,
2024–2031 (USD MILLION) 603
TABLE 877 UAE: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 604
TABLE 878 UAE: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 604
TABLE 879 UAE: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE,
2024–2031 (USD MILLION) 605
TABLE 880 UAE: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE,
2024–2031 (USD MILLION) 605
TABLE 881 UAE: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 606
TABLE 882 UAE: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,
2024–2031 (USD MILLION) 606
TABLE 883 UAE: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 606
TABLE 884 UAE: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE,
2024–2031 (USD MILLION) 607
TABLE 885 UAE: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE,
2024–2031 (USD MILLION) 607
TABLE 886 UAE: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING,
BY TYPE, 2024–2031 (USD MILLION) 608
TABLE 887 UAE: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 608
TABLE 888 UAE: AI IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 608
TABLE 889 UAE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE,
2024–2031 (USD MILLION) 609
TABLE 890 UAE: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE,
2024–2031 (USD MILLION) 609
TABLE 891 REST OF GCC: AI IN HEALTHCARE MARKET, BY OFFERING,
2024–2031 (USD MILLION) 610
TABLE 892 REST OF GCC: AI IN HEALTHCARE MARKET, BY FUNCTION,
2024–2031 (USD MILLION) 610
TABLE 893 REST OF GCC: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024–2031 (USD MILLION) 611
TABLE 894 REST OF GCC: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,
2024–2031 (USD MILLION) 611
TABLE 895 REST OF GCC: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,
2024–2031 (USD MILLION) 612
TABLE 896 REST OF GCC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,
BY APPLICATION, 2024–2031 (USD MILLION) 612
TABLE 897 REST OF GCC: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,
BY MODALITY, 2024–2031 (USD MILLION) 613
TABLE 898 REST OF GCC: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 613
TABLE 899 REST OF GCC: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 614
TABLE 900 REST OF GCC: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY,
BY TYPE, 2024–2031 (USD MILLION) 614
TABLE 901 REST OF GCC: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 615
TABLE 902 REST OF GCC: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024–2031 (USD MILLION) 615
TABLE 903 REST OF GCC: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 616
TABLE 904 REST OF GCC: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 616
TABLE 905 REST OF GCC COUNTRIES: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 617
TABLE 906 REST OF GCC: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 617
TABLE 907 REST OF GCC: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT,
BY TYPE, 2024–2031 (USD MILLION) 618
TABLE 908 REST OF GCC: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE,
2024–2031 (USD MILLION) 618
TABLE 909 REST OF GCC: AI IN HEALTHCARE MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 619
TABLE 910 REST OF GCC: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,
2024–2031 (USD MILLION) 619
TABLE 911 REST OF GCC: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 619
TABLE 912 REST OF GCC: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024–2031 (USD MILLION) 620
TABLE 913 REST OF GCC: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE,
2024–2031 (USD MILLION) 620
TABLE 914 REST OF GCC: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024–2031 (USD MILLION) 621
TABLE 915 REST OF GCC: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING,
BY TYPE, 2024–2031 (USD MILLION) 621
TABLE 916 REST OF GCC: AI IN HEALTHCARE MARKET, BY END USER,
2024–2031 (USD MILLION) 621
TABLE 917 REST OF GCC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2024–2031 (USD MILLION) 622
TABLE 918 REST OF GCC: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024–2031 (USD MILLION) 622
TABLE 919 SOUTH AFRICA: AI IN HEALTHCARE MARKET, BY OFFERING,
2024–2031 (USD MILLION) 623
TABLE 920 SOUTH AFRICA: AI IN HEALTHCARE MARKET, BY FUNCTION,
2024–2031 (USD MILLION) 624
TABLE 921 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024–2031 (USD MILLION) 624
TABLE 922 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR IVD, BY TECHNOLOGY,
2024–2031 (USD MILLION) 625
TABLE 923 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR IVD, BY APPLICATION,
2024–2031 (USD MILLION) 625
TABLE 924 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,
BY APPLICATION, 2024–2031 (USD MILLION) 625
TABLE 925 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING,
BY MODALITY, 2024–2031 (USD MILLION) 626
TABLE 926 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 626
TABLE 927 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 627
TABLE 928 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 627
TABLE 929 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 628
TABLE 930 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024–2031 (USD MILLION) 628
TABLE 931 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 629
TABLE 932 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 629
TABLE 933 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 630
TABLE 934 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE, 2024–2031 (USD MILLION) 630
TABLE 935 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT,
BY TYPE, 2024–2031 (USD MILLION) 631
TABLE 936 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024–2031 (USD MILLION) 631
TABLE 937 SOUTH AFRICA: AI IN HEALTHCARE MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 632
TABLE 938 SOUTH AFRICA: AI IN HEALTHCARE MARKET, BY DEPLOYMENT MODEL,
2024–2031 (USD MILLION) 632
TABLE 939 SOUTH AFRICA: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 632
TABLE 940 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024–2031 (USD MILLION) 633
TABLE 941 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024–2031 (USD MILLION) 633
TABLE 942 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024–2031 (USD MILLION) 634
TABLE 943 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 634
TABLE 944 SOUTH AFRICA: AI IN HEALTHCARE MARKET, BY END USER,
2024–2031 (USD MILLION) 634
TABLE 945 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2024–2031 (USD MILLION) 635
TABLE 946 SOUTH AFRICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024–2031 (USD MILLION) 635
TABLE 947 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY OFFERING, 2024–2031 (USD MILLION) 636
TABLE 948 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY FUNCTION, 2024–2031 (USD MILLION) 636
TABLE 949 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSIS & EARLY DETECTION, BY TYPE, 2024–2031 (USD MILLION) 637
TABLE 950 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IVD,
BY TECHNOLOGY, 2024–2031 (USD MILLION) 637
TABLE 951 REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IVD,
BY APPLICATION, 2024–2031 (USD MILLION) 638
TABLE 952 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY APPLICATION, 2024–2031 (USD MILLION) 638
TABLE 953 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DIAGNOSTIC IMAGING, BY MODALITY, 2024–2031 (USD MILLION) 639
TABLE 954 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR TREATMENT PLANNING & PERSONALIZATION, BY TYPE, 2024–2031 (USD MILLION) 639
TABLE 955 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PERSONALIZED TREATMENT PLANNING, BY TYPE, 2024–2031 (USD MILLION) 640
TABLE 956 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PHARMACOLOGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 640
TABLE 957 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR SURGICAL THERAPY, BY TYPE, 2024–2031 (USD MILLION) 641
TABLE 958 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR RADIATION THERAPY, BY TYPE, 2024–2031 (USD MILLION) 641
TABLE 959 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR BEHAVIORAL THERAPY & PSYCHOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 642
TABLE 960 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR IMMUNOTHERAPY, BY TYPE, 2024–2031 (USD MILLION) 642
TABLE 961 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PATIENT ENGAGEMENT & REMOTE MONITORING, BY TYPE, 2024–2031 (USD MILLION) 643
TABLE 962 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR POST-TREATMENT SURVEILLANCE & SURVIVORSHIP CARE, BY TYPE,
2024–2031 (USD MILLION) 643
TABLE 963 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR PHARMACY MANAGEMENT, BY TYPE, 2024–2031 (USD MILLION) 644
TABLE 964 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR ADMINISTRATIVE, BY TYPE, 2024–2031 (USD MILLION) 644
TABLE 965 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 645
TABLE 966 REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET,
BY DEPLOYMENT MODEL, 2024–2031 (USD MILLION) 645
TABLE 967 REST OF THE MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY TOOL, 2024–2031 (USD MILLION) 645
TABLE 968 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR MACHINE LEARNING, BY TYPE, 2024–2031 (USD MILLION) 646
TABLE 969 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR DEEP LEARNING, BY TYPE, 2024–2031 (USD MILLION) 646
TABLE 970 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR NATURAL LANGUAGE PROCESSING, BY TYPE, 2024–2031 (USD MILLION) 647
TABLE 971 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR CONTEXT-AWARE COMPUTING, BY TYPE, 2024–2031 (USD MILLION) 647
TABLE 972 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 647
TABLE 973 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 648
TABLE 974 REST OF MIDDLE EAST & AFRICA: AI IN HEALTHCARE MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024–2031 (USD MILLION) 648
TABLE 975 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN AI IN HEALTHCARE MARKET, JANUARY 2023–JUNE 2026 649
TABLE 976 AI IN HEALTHCARE MARKET SHARE ANALYSIS, 2025 654
TABLE 977 AI IN HEALTHCARE MARKET: REGION FOOTPRINT 658
TABLE 978 AI IN HEALTHCARE MARKET: APPLICATION FOOTPRINT 659
TABLE 979 AI IN HEALTHCARE MARKET: TOOL FOOTPRINT 660
TABLE 980 AI IN HEALTHCARE MARKET: FUNCTION FOOTPRINT, 2025 661
TABLE 981 AI IN HEALTHCARE MARKET: OFFERING FOOTPRINT 662
TABLE 982 AI IN HEALTHCARE MARKET: DEPLOYMENT FOOTPRINT 663
TABLE 983 AI IN HEALTHCARE MARKET: END USER FOOTPRINT, 2025 664
TABLE 984 AI IN HEALTHCARE MARKET: DETAILED LIST OF KEY STARTUP/SME
PLAYERS, 2025 667
TABLE 985 AI IN HEALTHCARE MARKET: APPLICATION AND REGIONAL FOOTPRINT (STARTUPS/SMES), 2025 667
TABLE 986 AI IN HEALTHCARE MARKET: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS, JANUARY 2023–JUNE 2026 669
TABLE 987 AI IN HEALTHCARE MARKET: DEALS, JANUARY 2023–JUNE 2026 671
TABLE 988 AI IN HEALTHCARE MARKET: OTHER DEVELOPMENTS, JANUARY 2023–JUNE 2026 672
TABLE 989 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 673
TABLE 990 KONINKLIJKE PHILIPS N.V.: PRODUCTS & SERVICES OFFERED 674
TABLE 991 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 676
TABLE 992 KONINKLIJKE PHILIPS N.V.: DEALS 678
TABLE 993 KONINKLIJKE PHILIPS N.V.: EXPANSIONS 680
TABLE 994 KONINKLIJKE PHILIPS N.V.: OTHER DEVELOPMENTS 681
TABLE 995 MICROSOFT CORPORATION: COMPANY OVERVIEW 682
TABLE 996 MICROSOFT CORPORATION: PRODUCTS & SERVICES OFFERED 683
TABLE 997 MICROSOFT CORPORATION: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 685
TABLE 998 MICROSOFT CORPORATION: DEALS 686
TABLE 999 NVIDIA CORPORATION: COMPANY OVERVIEW 689
TABLE 1000 NVIDIA CORPORATION: PRODUCTS & SERVICES OFFERED 690
TABLE 1001 NVIDIA CORPORATION: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 691
TABLE 1002 NVIDIA CORPORATION: DEALS 692
TABLE 1003 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW 695
TABLE 1004 SIEMENS HEALTHINEERS AG: PRODUCTS & SERVICES OFFERED 696
TABLE 1005 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 698
TABLE 1006 SIEMENS HEALTHINEERS AG: DEALS 699
TABLE 1007 GE HEALTHCARE: COMPANY OVERVIEW 702
TABLE 1008 GE HEALTHCARE: PRODUCTS & SERVICES OFFERED 703
TABLE 1009 GE HEALTHCARE: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 705
TABLE 1010 GE HEALTHCARE: DEALS 705
TABLE 1011 GE HEALTHCARE: OTHER DEVELOPMENTS 707
TABLE 1012 EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW 708
TABLE 1013 EPIC SYSTEMS CORPORATION: PRODUCTS & SERVICES OFFERED 708
TABLE 1014 EPIC SYSTEMS CORPORATION: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 709
TABLE 1015 EPIC SYSTEMS CORPORATION: DEALS 709
TABLE 1016 ORACLE: COMPANY OVERVIEW 710
TABLE 1017 ORACLE: PRODUCTS & SERVICES OFFERED 711
TABLE 1018 ORACLE: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 712
TABLE 1019 ORACLE CORPORATION: DEALS 713
TABLE 1020 ORACLE: EXPANSIONS 714
TABLE 1021 VERADIGM LLC: COMPANY OVERVIEW 715
TABLE 1022 VERADIGM LLC: PRODUCTS & SERVICES OFFERED 715
TABLE 1023 VERADIGM LLC: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 716
TABLE 1024 VERADIGM LLC: DEALS 717
TABLE 1025 AMAZON WEB SERVICES, INC.: COMPANY OVERVIEW 718
TABLE 1026 AMAZON WEB SERVICES, INC.: PRODUCTS & SERVICES OFFERED 719
TABLE 1027 AMAZON WEB SERVICES, INC.: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 720
TABLE 1028 AMAZON WEB SERVICES, INC.: DEALS 721
TABLE 1029 AMAZON WEB SERVICES, INC.: EXPANSIONS 722
TABLE 1030 MERATIVE: COMPANY OVERVIEW 723
TABLE 1031 MERATIVE: PRODUCTS & SERVICES OFFERED 723
TABLE 1032 MERATIVE: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 724
TABLE 1033 MERATIVE: DEALS 724
TABLE 1034 IBM: COMPANY OVERVIEW 725
TABLE 1035 IBM: PRODUCTS & SERVICES OFFERED 726
TABLE 1036 IBM: DEALS 727
TABLE 1037 MEDTRONIC: COMPANY OVERVIEW 728
TABLE 1038 MEDTRONIC: PRODUCTS & SERVICES OFFERED 729
TABLE 1039 MEDTRONIC: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 730
TABLE 1040 MEDTRONIC: DEALS 731
TABLE 1041 GOOGLE: COMPANY OVERVIEW 732
TABLE 1042 GOOGLE: PRODUCTS & SERVICES OFFERED 733
TABLE 1043 GOOGLE: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 735
TABLE 1044 GOOGLE: DEALS 736
TABLE 1045 GOOGLE: OTHER DEVELOPMENTS 738
TABLE 1046 SOPHIA GENETICS: COMPANY OVERVIEW 739
TABLE 1047 SOPHIA GENETICS: PRODUCTS & SERVICES OFFERED 740
TABLE 1048 SOPHIA GENETICS: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 740
TABLE 1049 SOPHIA GENETICS: DEALS 741
TABLE 1050 SOPHIA GENETICS: OTHER DEVELOPMENTS 742
TABLE 1051 JOHNSON & JOHNSON SERVICES, INC.: COMPANY OVERVIEW 743
TABLE 1052 JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS & SERVICES OFFERED 744
TABLE 1053 JOHNSON & JOHNSON SERVICES, INC.: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 745
TABLE 1054 JOHNSON & JOHNSON SERVICES, INC.: DEALS 745
TABLE 1055 TEMPUS AI, INC.: COMPANY OVERVIEW 746
TABLE 1056 TEMPUS AI, INC.: PRODUCTS & SERVICES OFFERED 747
TABLE 1057 TEMPUS AI, INC.: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 748
TABLE 1058 TEMPUS AI, INC.: DEALS 749
TABLE 1059 CONCERTAI: COMPANY OVERVIEW 751
TABLE 1060 CONCERTAI: PRODUCTS & SERVICES OFFERED 751
TABLE 1061 CONCERTAI: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 752
TABLE 1062 CONCERTAI: DEALS 753
TABLE 1063 SOLVENTUM CORPORATION: COMPANY OVERVIEW 755
TABLE 1064 SOLVENTUM CORPORATION: PRODUCTS & SERVICES OFFERED 756
TABLE 1065 SOLVENTUM CORPORATION: DEALS 757
TABLE 1066 SOLVENTUM CORPORATION: OTHER DEVELOPMENTS 758
TABLE 1067 COGNIZANT: COMPANY OVERVIEW 759
TABLE 1068 COGNIZANT: PRODUCTS & SERVICES OFFERED 760
TABLE 1069 COGNIZANT: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 761
TABLE 1070 COGNIZANT: DEALS 762
TABLE 1071 VIZ.AI, INC.: COMPANY OVERVIEW 763
TABLE 1072 VIZ.AI, INC.: PRODUCTS & SERVICES OFFERED 763
TABLE 1073 VIZ.AI, INC.: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 764
TABLE 1074 VIZ.AI, INC.: DEALS 764
TABLE 1075 VIZ.AI, INC.: OTHER DEVELOPMENTS 766
TABLE 1076 RIVERAIN TECHNOLOGIES: COMPANY OVERVIEW 767
TABLE 1077 RIVERAIN TECHNOLOGIES: PRODUCTS & SERVICES OFFERED 767
TABLE 1078 RIVERAIN TECHNOLOGIES: PRODUCT LAUNCHES/ENHANCEMENTS/APPROVALS 768
TABLE 1079 RIVERAIN TECHNOLOGIES: DEALS 768
TABLE 1080 STUDY ASSUMPTIONS 785
TABLE 1081 AI IN HEALTHCARE MARKET: RISK ASSESSMENT 786

LIST OF FIGURES

FIGURE 1 MARKETS COVERED AND REGIONAL SCOPE 67
FIGURE 2 DURATION COVERED IN REPORT 71
FIGURE 3 MARKET SCENARIO 74
FIGURE 4 GLOBAL AI IN HEALTHCARE MARKET, 2024–2031 74
FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN AI IN HEALTHCARE MARKET, 2023–2026 75
FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF AI IN HEALTHCARE MARKET 76
FIGURE 7 HIGH-GROWTH SEGMENTS IN AI IN HEALTHCARE MARKET, 2026–2031 77
FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN AI IN HEALTHCARE MARKET,
IN TERMS OF VALUE, DURING FORECAST PERIOD 78
FIGURE 9 RAPID PROLIFERATION OF AI IN HOSPITALS TO DRIVE GROWTH OF AI IN HEALTHCARE MARKET 79
FIGURE 10 CLINICAL APPLICATIONS AND US ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2025 80
FIGURE 11 INDIA TO REGISTER HIGHEST GROWTH RATE IN GLOBAL AI IN HEALTHCARE MARKET DURING FORECAST PERIOD 80
FIGURE 12 AI IN HEALTHCARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 81
FIGURE 13 AI IN HEALTHCARE MARKET: PORTER’S FIVE FORCES ANALYSIS 95
FIGURE 14 AI IN HEALTHCARE MARKET: VALUE CHAIN ANALYSIS 98
FIGURE 15 AI IN HEALTHCARE ECOSYSTEM ANALYSIS 99
FIGURE 16 TRENDS/DISRUPTIONS INFLUENCING CUSTOMER BUSINESSES 103
FIGURE 18 JURISDICTION AND TOP APPLICANT ANALYSIS FOR AI IN HEALTHCARE MARKET 114
FIGURE 19 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR AI IN HEALTHCARE MARKET (JANUARY 2015 TO DECEMBER 2025) 115
FIGURE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS 125
FIGURE 21 KEY BUYING CRITERIA FOR TOP 3 END USERS 126
FIGURE 22 NORTH AMERICA: AI IN HEALTHCARE MARKET SNAPSHOT 269
FIGURE 23 ASIA PACIFIC: AI IN HEALTHCARE MARKET SNAPSHOT 411
FIGURE 24 REVENUE ANALYSIS OF KEY PLAYERS IN AI IN HEALTHCARE MARKET, 2021–2025 652
FIGURE 25 MARKET SHARE ANALYSIS OF KEY PLAYERS IN AI IN HEALTHCARE MARKET, 2025 653
FIGURE 26 AI IN HEALTHCARE MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2025 656
FIGURE 27 AI IN HEALTHCARE MARKET: COMPANY FOOTPRINT, 2025 657
FIGURE 28 AI IN HEALTHCARE MARKET: COMPANY EVALUATION MATRIX
(STARTUPS/SMES), 2025 666
FIGURE 29 EV/EBITDA OF KEY VENDORS, 2026 668
FIGURE 30 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF
KEY VENDORS, 2026 668
FIGURE 31 AI IN HEALTHCARE MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 669
FIGURE 32 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT 674
FIGURE 33 MICROSOFT CORPORATION: COMPANY SNAPSHOT 683
FIGURE 34 NVIDIA CORPORATION: COMPANY SNAPSHOT 690
FIGURE 35 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT 696
FIGURE 36 GE HEALTHCARE: COMPANY SNAPSHOT 703
FIGURE 37 ORACLE: COMPANY SNAPSHOT 711
FIGURE 38 AMAZON WEB SERVICES, INC.: COMPANY SNAPSHOT 719
FIGURE 39 IBM: COMPANY SNAPSHOT 726
FIGURE 40 MEDTRONIC: COMPANY SNAPSHOT 729
FIGURE 41 GOOGLE: COMPANY SNAPSHOT 733
FIGURE 42 SOPHIA GENETICS: COMPANY SNAPSHOT 739
FIGURE 43 JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT 744
FIGURE 44 TEMPUS: COMPANY SNAPSHOT 747
FIGURE 45 SOLVENTUM CORPORATION: COMPANY SNAPSHOT 756
FIGURE 46 COGNIZANT: COMPANY SNAPSHOT 760
FIGURE 47 RESEARCH DESIGN 774
FIGURE 48 KEY DATA FROM SECONDARY SOURCES 776
FIGURE 49 PRIMARY SOURCES 777
FIGURE 50 KEY INSIGHTS FROM INDUSTRY EXPERTS 778
FIGURE 51 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE), BY COMPANY TYPE, DESIGNATION, AND REGION 779
FIGURE 52 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 780
FIGURE 53 BOTTOM-UP APPROACH: END USER SPENDING ON AI IN HEALTHCARE 781
FIGURE 54 AI IN HEALTHCARE MARKET: CAGR PROJECTION FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 782
FIGURE 55 CAGR PROJECTION: SUPPLY-SIDE ANALYSIS 783
FIGURE 56 TOP-DOWN APPROACH 783
FIGURE 57 DATA TRIANGULATION METHODOLOGY 784

---

---